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Abstract 
Engineering Biomolecular Interfaces for Applications in Biotechnology 
 
Beyza Bulutoglu 
Protein interactions occurring through biomolecular interfaces play an important role in 
the circle of life. These interactions are responsible for cellular function, including RNA 
transcription, protein translation, cell division and cell death among many others. There 
are different types of interactions based on the strength and the duration of the 
association. Transient interactions govern most steps of the cellular metabolism, where 
the associations between two or more molecules are responsive to environmental cues. 
Among the participants of transient interactions, intrinsically disordered proteins are 
employed in signaling and other regulatory events within the cell. These proteins exhibit 
allosteric regulation and gain secondary structure when they bind other proteins or small 
molecules.  
 In this doctoral thesis work, the biochemical and biophysical principals governing 
protein associations are investigated and using protein engineering tools, novel 
biomolecular interfaces are engineered, with potential applications in different areas of 
biotechnology. The first part of the thesis (Chapter 2) focuses on the investigation of 
supramolecular enzyme association among tricarboxylic acid cycle enzymes, specifically 
between citrate synthase and mitochondrial malate dehydrogenase. In this study, the 
interactions between these enzymes are examined, both among their natural and 
synthetically produced recombinant versions. In addition, mutational analysis of the 
amino acid residues at the complex interface was performed to explore the importance of 
the positively charged patch connecting the active sites of the enzymes. It was discovered 
that the channeling of the negatively charged intermediate is severely impaired upon 
mutation of surface residues contributing to the electrostatic channeling. This work 
provides an important insight into understanding the coupled reaction-transport systems 
and metabolon formation in general. In addition, it constitutes a great example for 
substrate channeling in leaky systems, which are relevant to most biological processes. 
 The next section of the thesis (Chapter 3) focuses on an intrinsically disordered 
peptide, the β-roll. This peptide is isolated from the Block V repeats-in-toxin (RTX) 
domain of adenylate cyclase from Bordetella pertussis. It is disordered in the absence of 
calcium and it folds into a β-roll secondary structure composed of two parallel β-sheet 
faces upon binding to calcium ions. This way, the peptide can transition between its 
unfolded state and the β-roll structure in a reversible way. We have utilized the allosteric 
regulation of this domain as a tool to engineer new protein interfaces. In its folded state, 
the peptide has two faces, serving as binding surfaces available for interaction with other 
proteins. Our work involved the alteration of the residues, which form these faces upon 
calcium binding, via combinatorial protein design techniques.  
 The potential of this peptide is evaluated as a cross-linking domain for hydrogel 
formation. By rationally engineering the two faces of the folded β-roll to contain leucine 
residues, we have created hydrophobic interfaces, serving as environmentally-responsive 
cross-linking domains. When there is no calcium, the β-roll domains remain unstructured, 
delocalizing the leucine rich patches. After calcium binding, the β-rolls fold and the 
leucine rich faces are exposed creating a hydrophobic driving force for self-assembly. 
This way, we showed that the β-roll peptide can function as a biomaterials building block 
capable of proteinaceous hydrogel formation, only in the presence of calcium. 
 The next study (Chapter 4) demonstrates the utilization of this peptide as an 
alternative scaffold for biomolecular recognition applications. A library of mutant β-rolls 
was constructed by randomizing the amino acid residues on one of the β-sheet forming 
faces. Mutant peptides demonstrating an affinity for hen egg white lysozyme were 
selected, which was chosen as a model target molecule. The thermodynamic parameters 
of the interactions between the β-roll mutants and the lysozyme were quantified. Upon 
performing further protein engineering (e.g. concatenation of the single mutants on the 
DNA level), a mutant with mid-nanomolar affinity was identified. Affinity 
chromatography experiments showed that this mutant was capable of capturing the target, 
in the presence of calcium. The captured target was easily released upon removal of the 
calcium ions. The reversibility of the calcium binding allowed the engineered molecular 
interface to be controllable. Throughout this study, the β-roll peptide was explored as an 
allosterically-regulated protein switch for on/off biomolecular recognition, which can be 
mediated by simply changing the calcium concentration, allowing control over the 
binding behavior between molecules. 
 The last part of the thesis (Chapter 5) expands on the calcium dependent network 
formation study. A hydrogel construct was genetically built by fusing the cross-linking  
β-roll domain and the lysozyme binding β-roll mutant, resulting in a smart biomaterial 
with dual-functionality. The network-assembly and target capture functions of this 
construct were tested by various assays including hydrogel erosion experiments. This 
allosterically-regulated biomaterial exhibited promising results, where calcium-dependent 
lysozyme entrapment within the assembled network and lysozyme capture on the 
hydrogel surface were demonstrated. 
 The work presented in this thesis demonstrates different approaches to understand 
and engineer molecular interfaces in both natural and recombinant systems. In the future, 
these approaches and the knowledge gained from these studies can be further built upon 
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1.1 Protein-Protein Interactions 
The interactions between proteins within the cell are responsible for the continuity of life. 
They contribute to vital biological processes including regulation of DNA replication, 
membrane transport, signal transduction within and between cells, and cellular 
metabolism. There are different types of protein-protein interactions (PPIs) based on the 
composition of the involved intramolecular and intermolecular forces, on the interaction 
affinities as well as the lifetime of the associations. In addition, PPIs can involve obligate 
complexes such as enzyme oligomerization and promoter complexes or non-obligate 
associations, such as the interactions between an enzyme and its inhibitor or antibody-
antigen interactions. The proteins involved in non-obligate interactions can exist 
independently and these interactions can be established or broken according to 
environmental factors. The combination of van der Waals interactions, electrostatic 
forces, hydrogen bonds and hydrophobic interactions between individual amino acids 
displayed on the protein surfaces results in association between two or more proteins.1-12 
 The dynamics of the cellular function require different levels of control over PPIs. 
Some interactions can be very stable such as those in subunits of a protein complex or 
homo-oligomeric proteins (e.g. cytochrome C).1 Even though many interactions cannot 
be assigned to a distinct classification, transient interactions are more common where 
!
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proteins bind each other reversibly to carry out a specific cellular process. These PPIs can 
be strong or weak depending on their cellular function (Fig. 1.1).5 They can associate and 










Figure 1.1 Classification of PPIs based on their binding affinities. In permanent 
associations, proteins bind each other with dissociation constants in the nM and even in 
the pM range. In transient interactions, the binding event can be reversible and these PPIs 
have lower dissociation constants, usually in the range of µM - mM.1, 5, 13 
 
1.2 Understanding PPIs in Natural Systems 
Since PPIs are the core of most biological processes, understanding recognition and 
binding events at the biomolecular interfaces is important. These associations should be 
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identified and understood in order to learn the mechanisms governing most cellular 
functions and to be able to apply this knowledge in a beneficial way to humankind. There 
has been a great amount of research devoted to the investigation of abnormal protein 
interactions, which play a major role in various diseases ranging from cancer to 
neurodegenerative diseases (e.g. amyloid fibril formation, which is observed in patients 
with Alzheimer’s disease).3, 14-16 
 Another large research area in the investigation of PPIs focuses on enzyme-
enzyme interactions. Enzymes are highly specific catalysts, which are responsible for the 
degradation and synthesis of molecules within the factory that is the cell. In one second, 
more than one billion reactions take place in the human body. PPIs play a major role in 
enzymes’ overall efficiency and studying these interactions would expand our current 
knowledge about metabolic processes. 
 
1.2.1 Enzyme Complexes 
In nature, most enzymes belong to cascades, where they exist as parts of sequential multi-
enzyme pathways. It has been established that significant co-localization of enzymes 
exists within a metabolic cascade. Consecutive enzymes in a pathway can come in close 
proximity and form a multi-enzyme cluster, as their quinary structures. Srere and his co-
workers introduced the term “metabolon” in 1985, to describe these structural enzyme 
complexes.17, 18 
 Metabolon formation results in substrate channeling, where the product of an 
enzyme in the cycle, being the substrate of the next one, is transferred to the next enzyme 
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without being released into the bulk medium. This mechanism provides several 
advantages resulting in the improvement of overall efficiency of the cycle. Within a 
metabolon, the active sites of the enzymes are in close proximity and the metabolites 
channel from one active site to the adjacent one. This way, a substrate does not have to 
reach equilibrium with the surrounding environment. In addition, unstable intermediates 
are protected and the competition among alternative pathways is hindered. All of these 
effects result in enhanced overall transport within the cycle and improved reaction rates 
compared to free enzyme counterparts.19-21 
 Enzyme complex formation takes place in various pathways, including glycolysis, 
fatty acid oxidation, amino acid metabolism, lipid biosynthesis and tricarboxylic acid 
(TCA) cycle. In tryptophan synthase complex, a physical tunnel was found, connecting 
the two active sites, through which the intermediate can pass. In other enzymes, such as 
malate dehydrogenase and citrate synthase, electrostatic interactions play a role in the 
metabolon formation.18, 22, 23 
 Despite being the focus of intense research in the field of enzymology, most 
findings about metabolons and substrate channeling are based on indirect experimental 
evidence due to the complexities associated with unambiguous demonstration of the 
existence of such formations (e.g. dissociation of the complex upon isolation due to 
dilution effects). Related fundamental characterization studies were limited to the 
tunneling occurring in completely bound systems (e.g. tryptophan synthase). However 
the bounded diffusion mechanism within the metabolon, e.g. the leaky channeling of 
substrates, which is more relevant to most biological systems, is not well understood.24-27 
!
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1.2.2 TCA Cycle Enzymes 
TCA cycle is responsible for energy generation in aerobic organisms through the 
oxidation of acetate, which is obtained from nutrients such as carbohydrates and fats. 
Several enzymes of this cycle have been shown to be involved in the formation of 
metabolons, including citrate synthase, malate dehydrogenase and aconitase. The 
proximity of active sites of enzymes, specific protein-protein interactions as well as 
protein-membrane interactions (the inner membrane of mitochondria) are thought to be 
involved in the formation of structural-functional complexes within the TCA cycle.23 
 Early predictions on the possible interactions within these enzymes were mainly 
based on the fact that the concentration of free oxaloacetate is too low to sustain the cycle 
rate, which is produced by malate dehydrogenase and converted to citrate by citrate 
synthase. In addition, malate dehydrogenase’s equilibrium state is highly unfavorable in 
comparison to the overall direction of the cycle.28, 29 Several groups performed 
experiments with whole mitochondria, fusion proteins and immobilized enzymes. A 
model of the fusion proteins showed that the thermodynamically favorable orientation 
has interacting surface areas with electrostatic interactions. However, the exact 
mechanism of the metabolon formation among these enzymes has not been fully 







1.3 Transient Interactions 
As demonstrated by the interactions between enzymes, non-obligate, transient 
interactions are important for the dynamic state within the cell, and they are 
physicochemically regulated. These types of interactions are observed in regulatory 
networks, where they can form and terminate upon perturbations in the cellular 
environment such as changes in metabolite concentrations. They are employed in a wide 
range of functions including cell division, energy generation, intracellular transport, 
signaling cascades and correction of misfolded proteins.32, 33 
 Transient PPIs demonstrate a wide spectrum of lifetimes and affinities (Fig. 1.1). 
On the one end of the spectrum are interactions with high affinities and long association 
times (e.g. hours to days) such as antibody-antigen interactions. Some of these may be 
classified as permanent interactions as well, depending on the context they are being 
studied in. On the other end of the spectrum lie the weak transient interactions. Among 
these weak-affinity transient PPIs, structural disorder in protein interfaces is frequently 
observed. Intrinsically disordered proteins are mostly employed in transient protein 
interactions, where disorder-to-order switch takes place upon association.5, 32, 34 
 
1.3.1 Intrinsically Disordered Proteins 
Intrinsically disordered protein and peptides (IDPs) lack a stable secondary/tertiary 
structure and they undergo induced folding upon interacting with their binding partners. 
Some proteins can be intrinsically disordered as a whole whereas some proteins have 
disordered regions. Their folding can be actuated by other proteins, nucleic acids or small 
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molecules, such as ions. IDPs bind their target molecules with low affinity and high 
specificity. These proteins are usually employed in signaling and cellular control 
processes, such as protein phosphorylation, as well as in molecular assembly, where a 
number of IDPs can bind to the same set of proteins to stabilize their structure. They 
possess a broad functional diversity and can gain different structures upon interaction 
with different partners. This behavior is exemplified by the p53 molecule, which is a 
transcription factor involved in anticancer function, that has intrinsically disordered 
regions on its N- and C-termini. This tumor suppressor can fold into different structures 
upon binding to different molecules. Titin, one of the largest proteins within the body, 
has an intrinsically disordered domain, which is responsible for most of the elasticity of 
the protein and is employed in stress sensing.35-41  
 
1.3.2 RTX Domains 
Proteins with repeat-in-toxin (RTX) domains are among the largest family of IDPs. These 
domains are present in most lipases (e.g. lipase A from Serratia marcescens) and 
proteases (e.g. alkaline protease from Pseudomonas aeruginosa), in gram-negative 
bacteria. RTX domains have a repetitive sequence, composed of several blocks of 
GGXGXDXUX, where U represents an aliphatic amino acid and any residue can be in 
position X. They become biologically activated upon calcium binding, following which 
they serve as molecular chaperons or as the folding nuclei for the rest of the protein. 
Virulence factors, such as Escherichia coli α-hemolysin (HlyA), depend on their RTX 
domains for the initial interactions with the target cells.42-47 
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1.3.3 The β-roll Peptide 
The adenylate cyclase toxin (CyaA) of Bordetella pertussis is one of the most studied 
RTX family of proteins. It is employed in the bacterial type 1 secretion system, where it 
assists with the protein transport across the cell membrane. CyaA has five blocks of RTX 
domains and the β-roll peptide is taken from the block V domain. It is intrinsically 
disordered in the intracellular space, where the calcium concentration is low. Upon 
secretion into the extracellular space, where the calcium concentration is in the 
millimolar range, it folds into its secondary structure, a β-helix composed of turns and 
parallel β-sheets as shown in Figure 1.2.48-51 
Figure 1.2 Disordered to structured transition of the β-roll upon calcium binding. 
The structure of the peptide and its primary protein sequence are shown (PDB: 5CVW). 
 The β-roll has a glycine and aspartic acid rich consensus sequence with repeats of 
the 9 amino acids: GGXGXDX(L/I)X, where X can be any amino acid residue. Calcium 
ions (shown in red in Fig. 1.2) are bound between two consecutive turns, for which the 
highly conserved aspartic acid residue is responsible (as demonstrated in blue in the 
peptide sequence). Upon folding, two amino acid residues in each β-strand (as 
demonstrated in green in the peptide sequence) face outwards and are exposed to the 
!
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solvent. It has been established that there is cooperativity in the conformational change of 
the β-roll because the binding of one calcium ion results in the formation of half of the 
binding site for the next ion. Thus, the binding of each calcium ion leads to an increase in 
the affinity of an adjacent binding site. In addition, C-terminal capping group (as 
demonstrated in grey in the peptide sequence) is found to be necessary for proper folding, 
entropically stabilizing the peptide.52-56 
 Previously, it has been shown that mutating the residues on one face to leucines 
resulted in the formation of a hydrophobic face amenable for cross-linking. Upon calcium 
addition, the β-roll folds, exposing its leucine rich face resulting in network formation. 
Thus, an allosterically regulated β-roll mutant was created for calcium dependent 
hydrogel formation. This approach can be applied to the second face of the peptide, 






Figure 1.3 Calcium controlled network assembly. If both faces of the peptide can be 
!
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made available for cross-linking, different hydrogel constructs can be built by fusing this 
mutant β-roll domain to other proteins (as demonstrated with the protein shown in pink).  
 In addition, this peptide is a good scaffold candidate for biomolecular recognition. 
The precise identification and mutation of the active interface is possible in proteins with 
repetitive sequences and with predictable secondary structures. Engineering of such 
scaffolds is easier to conduct, if one knows which residues are responsible for proper 
folding and which residues are involved in protein-protein interactions. Some of these 
repetitive motifs have been engineered to create nanomolar binders, including designed 
ankyrin repeats (DARPins). Engineering the β-roll would provide the design of an 
allosterically regulated scaffold, which would operate as a protein switch for 
biomolecular recognition.58-61 
 
1.4 Engineering PPIs in Synthetic Systems 
Modulating PPIs offers a broad range of applications to tackle biomedical problems and 
for therapeutic intervention as well as applications in various biotechnology areas. 
Protein-based materials can be utilized as drug delivery agents (e.g. hydrogels), in sensor 
applications (e.g. modified enzymes immobilized on electrodes), as therapeutics (e.g. 
engineered antibodies for immunotherapies), in bioseparations (e.g. protein A for 
antibody purification). There has also been an interest in the design of new protein 





1.4.1 Protein Engineering 
The naturally found twenty amino acids realize the synthesis of proteins. The genetic 
information carried on the DNA level is responsible for the structure and function of 
translated proteins. This relationship between the genetic sequence and resulting protein 
product constitutes the core of protein engineering. This research area focuses on the 
manipulation of a particular protein of interest at the genetic level and understanding the 
outcome of this manipulation at the functional protein level. Protein engineering provides 
a diverse toolbox, which can be utilized to answer following questions:  
• How does the protein of interest work? 
• How can we engineer this protein of interest to make it better/useful (by making it 
either functionally superior or employing it in a completely different context)? 
 Engineers have used this toolbox in synthetic, recombinant systems to investigate 
specific protein interactions, such as complex formation, by identifying the key residues 
contributing to the binding interface, and to improve specific properties of enzymes, such 
as catalytic activity or thermostability, as well as properties of other protein domains such 
as antibodies for enhanced binding affinity. There have been great advances in gene 
manipulation technologies, mutational analysis and library generation/screening 
platforms, as well as protein expression and purification systems. Combined with the 
genomic/proteomics technologies, these tools allow the cost-effective synthesis and 
manipulation of naturally found as well as non-natural, designed proteins; leading to the 
understanding of natural systems and to the engineering of existing as well as de novo 
proteins for biotechnology applications.70-74 
!
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1.4.2 Research Objectives 
In this thesis work, protein engineering tools have been applied to shed light on PPIs 
occurring in natural systems and to design biomolecular interfaces for new PPIs in 
completely synthetic systems. In Chapter 2, the interactions between TCA cycle 
enzymes, specifically mitochondrial malate dehydrogenase and citrate synthase, are 
discussed. This work investigates the supramolecular enzyme complex formation and 
substrate channeling among these enzymes and it specifically looks at the interface 
between the enzymes where mutational analysis was employed to probe the key residues 
contributing to the substrate channeling phenomenon.  
 The rest of the thesis work focuses on the intrinsically disordered β-roll domain. 
As discussed in section 1.3.3, in peptide’s folded conformation, the β-roll has two faces, 
serving as binding surfaces available for interaction with other proteins. Each β-strand in 
the β-roll face has two residues with solvent exposed side chains. These residues do not 
contribute to the peptide’s conformational stabilization or to calcium binding and they are 
highly variable among other RTX domains. This creates an opportunity to vary these 
pairs of amino acids for desired new functionalities, without compromising the unique 
and specific environmentally responsive behavior of this peptide. In addition, prior 
research showed that the β-roll’s transition between its unstructured and folded 
conformations, and its calcium responsiveness stay intact after the mutation of these 
positions to other amino acid residues. Considering these facts, it can be hypothesized 
that the amino acids on these β-helix faces are great locations to probe the peptide’s 
potential for different applications. The allosteric regulation of this peptide was utilized 
!
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as a tool to engineer new protein-protein interactions, which involved alteration of the 
residues that form these faces upon calcium binding, via combinatorial protein design 
techniques. 
 In Chapter 3, the potential of the β-roll is explored for stimulus responsive 
hydrogel formation. A new hydrophobic interface was engineered by creating a leucine-
rich β-roll face, capable of serving as a cross-linking domain. It is shown that these β-roll 
mutants can self-assemble via hydrophobic interactions and can from proteinaceous 
hydrogels, in the presence of calcium. The work presented in Chapter 4 focuses on the 
use of the β-roll peptide as an alternative scaffold to be employed in biomolecular 
recognition. In this work, the β-roll face was designed to serve as a surface area capable 
of forming interactions with a target molecule (lysozyme). By evolving this domain to 
exhibit molecular recognition towards a specific target in its folded conformation, control 
over the binding behavior between the β-roll and its target molecule was achieved. The 
allosteric regulation of this binding event was demonstrated via in vitro affinity 
chromatography applications. In Chapter 5, a new hydrogel platform is discussed which 
combines different β-roll mutants: the hydrogel building block β-roll mutant from 
Chapter 3, as the cross-linking domain, and the lysozyme binding β-roll mutant from 
Chapter 4, as the target capturing domain. This construct allows control of the self-
assembly and target binding within the hydrogel matrix by adjusting the calcium 
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Investigation of Metabolon Formation and 




Supramolecular assembly of enzymes into metabolon structures is thought to enable 
efficient transport of reactants between active sites via substrate channeling.   
Recombinant versions of porcine citrate synthtase (CS), mitochondrial malate 
dehydrogenase (mMDH) and aconitase (Aco) were found to adopt a homogeneous 
native-like metabolon structure in vitro.  Site-directed mutagenesis performed on highly 
conserved arginine residues located in the positively-charged channel connecting mMDH 
and CS active sites led to the identification of CS(R65A) which retained high catalytic 
efficiency. Substrate channeling between the CS mutant and mMDH is severely impaired 
and the overall channeling probability decreased from 0.99 to 0.023.  This work provides 
direct mechanistic evidence for the channeling of reaction intermediates and disruption of 
this interaction would have important implications on the control of flux in central carbon 
metabolism.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
†!A version of this chapter is published in ACS Chemical Biology (2016), 11: 2847-2853, with co-
authors Kristen Garcia, Fei Wu, Shelley Minteer and Scott Banta. B.B. designed and cloned the 
genes, expressed and purified the proteins, constructed mutant enzymes, performed transient time 




Enzymes frequently function in sequential, multi-step cascades and the co-localization of 
the enzymes in self-assembling clusters is often observed.1-3 The term “metabolon” has 
been used to describe these non-covalent dynamic enzyme complexes.4 These 
arrangements enable substrates to be channeled between active sites without escaping 
into the medium.5 When the intermediate transport is not 100 % efficient, leaky 
channeling can occur, but the intermediates are sequestered enough to prevent 
equilibrium with the surroundings.5-7  
 Substrate channeling within metabolons results in several metabolic advantages. 
High local substrate concentrations enable better fluxes through a pathway, despite 
unfavorable equilibrium constants. Intermediates can be protected from the bulk phase, 
hindering competition from alternative pathways and protecting the cell from toxicity. 
These effects on the mass transport allow the enzymes to operate at high efficiencies even 
when the average concentrations of intermediates in the bulk phase are low, resulting in 
the improvement of overall catalytic efficiency of the metabolic process.6-10  
 Metabolons exist in many pathways, including glycolysis, fatty acid oxidation, 
amino acid metabolism, lipid biosynthesis and the tricarboxylic acid (TCA) cycle.5, 11 
Several enzymes of the TCA cycle participate in metabolon formation, including citrate 
synthase (CS), mitochondrial malate dehydrogenase (mMDH) and aconitase (Aco).12-15 
Since they play a central role in cellular energy generation, metabolons of the TCA cycle 
have been well-studied.16-23 The CS/mMDH interactions are of particular interest since 
22 
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the free oxaloacetate (OAA) intermediate concentration in the cell is thought to be too 
low to sustain the experimentally determined cycle rate and the mMDH reaction has an 
unfavorable equilibrium constant in the forward direction of the cycle.20, 23  
 Most metabolon investigations employ indirect techniques to infer channeling.8, 14, 
21 Fundamental characterizations of substrate channeling have focused on enclosed 
channels such as the tunneling that occurs in tryptophan synthase.24-26 However, the 
bounded diffusion mechanism within the metabolon is more relevant to most biological 
systems.  And, it is becoming clear that these “leaky channeling” systems are inspiring 
new approaches in biocatalysis where coupled reaction/transport systems are being 
engineered with biomimetic substrate channeling pathways.7 Recently, the first structural 
characterization of a native mMDH-CS-Aco TCA cycle complex was reported.27 In this 
work, we created and characterized recombinant versions of the TCA cycle enzymes and 
this enables the use of site-directed mutagenesis to explore structural determinants of 
substrate channeling in vitro. 
 
2.3 Materials and Methods 
2.3.1 Genes, chemicals and bacterial strains 
Synthetic genes coding for the porcine heart enzymes were synthesized by Genscript. All 
genes have a Flag-tag at the N-terminus and a 6xHis-tag at the C-terminus, for 
identification and purification purposes, respectively. Restriction enzymes for DNA 
cloning were purchased from New England Biolabs. Isopropyl β-D-1-
23 
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thiogalactopyranoside (IPTG) and ampicillin sodium salt, were purchased from Gold 
Biotechnology. Amicon centrifugal filters were purchased from Millipore. 
Disuccinimidyl glutarate (DSG), sodium dodecyl sulfate polyacrylamide electrophoresis 
gels (SDS-PAGE) and running buffers were purchased from Invitrogen-Life 
Technologies. E. coli BL21 and BL21(DE3) cell lines were purchased from Bioline. 
Chaperon plasmid pGro7 was purchased from Clontech Laboratories–Takara. Ala-
chitosan was prepared as previously described.28 Fresh bovine heart was purchased from 
a local slaughterhouse and used immediately. All other reagents and materials were 
purchased from Sigma-Aldrich unless otherwise stated.  
 
2.3.2 Construction, expression and purification of enzymes 
2.3.2.1 Cloning of the synthetic genes into expression plasmids 
The genes coding for CS and Aco were cloned into pET-20b(+) backbone using the NdeI 
and HindIII restriction sites. Resulting plasmids were transformed into BL21(DE3) cells. 
mMDH was inserted into pMAL-c4e expression vector via the same restriction sites. The 
resulting construct and the chaperon plasmid pGro7 were co-transformed into BL21 cells 
for expression.   
 
2.3.2.2 Site-directed mutagenesis of recombinant CS 
CS Arg65 and Arg67 were mutated to alanine and aspartic acid to create single and 
double mutants via site-directed mutagenesis: CS(R65A), CS(R67A), CS(R65A/R67A), 
CS(R65D), CS(R67D), CS(R65D/R67D). CS(R65A) was used as the template to mutate 
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the Arg67 to alanine and CS(R65D) was used as the template to mutate Arg67 to aspartic 
acid. Corresponding primer sequences used during the PCR reaction are given in Table 
S2.1. 
 
2.3.2.3 Expression and purification of the recombinant enzymes 
All constructs were expressed in 1 L of sterilized Terrific Broth, inoculated with 10 ml 
overnight culture. For Aco and CS, the media was supplemented with 100 ug/mL 
ampicillin. 35 ug/mL chloramphenicol was added to mMDH cultures in addition to the 
ampicillin. The cells were grown to an OD600 of 0.6 while shaking at 37 °C and protein 
expression was induced with 0.5 mM IPTG for mMDH and CS, and with 0.6 mM IPTG 
for Aco. Expression was carried out for 18–20 h at 25 °C. Cells were harvested by 
centrifugation at 5000 × g for 10 min and resuspended in 50 mL HisTrap binding buffer 
(20 mM Tris, 150 mM NaCl and 20 mM imidazole, pH 7.4) per L of culture. Soluble 
proteins were collected via centrifugation at 15000 × g for 30 min after the cells were 
lysed by sonication with an ultrasonication probe in an ice bath for 6 min (5 s on pulse 
and 2 s off pulse). Enzymes of interest were purified by immobilized metal affinity 
chromatography using HisTrap columns (GE Healthcare Life Sciences), where bound 
enzymes were eluted with the elution buffer (20 mM Tris, 150 mM NaCl, 500 mM 
imidazole, pH 7.4). mMDH was buffer exchanged into 20 mM Tris-HCl (pH 8.7) and 
purified via anion exchange chromatography where the enzyme was eluted using a linear 
NaCl gradient from 0 to 1 M. All enzymes were further purified via size exclusion 
chromatography after buffer exchanging into 50 mM Tris, 150 mM NaCl, pH 7.4. 
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Amicon filters with 30 kDa (for mMDH and CS) and 50 kDa (for Aco) molecular weight 
cutoff were used in order to concentrate the protein solutions as well as to exchange the 
buffer in between different purification steps.  
 
2.3.2.4 Preparation of crude mitochondrial lysate 
Extraction of the bovine heart mitochondria was done according to the procedure 
described by Rogers et al. with some modifications.29 Bovine heart cubes were blended 
with cold isolation buffer (70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM 
EGTA and 0.5 % (w/v) BSA, pH 7.2) in a Waring laboratory blender. Meat suspension 
was centrifuged at 500 × g for 10 min and the supernatant was centrifuged at 26000 × g 
for 20 min. Pellet was homogenized in the isolation buffer and centrifuged twice again at 
500 × g for 10 min. Supernatant was filtered through a double-layer cheesecloth and 
centrifuged at 1000 × g for 20 min. The mitochondria pellet was washed with lysis buffer 
(50 mM Tris, 150 mM NaCl, 2 mM EDTA and 1 mM PMSF, pH 7.4) at 26000 × g for 10 
min. Pellet resuspended in the lysis buffer was sonicated with an ultrasonication probe in 
ice bath for 4 min (5 s on pulse and 15 s off pulse). The crude lysate was initially cleared 
at 5000 × g for 30 min. EDTA and PMSF were removed through the pre-packed 
SephadexTM G-25M column. Protein concentration in the mitochondrial lysate was 






2.3.3 Kinetic analysis 
2.3.3.1 Kinetic analysis of the recombinant enzymes 
mMDH and CS activity measurements were carried out as in Shatalin et al. with some 
modifications.17 mMDH was measured for activity with different substrate concentrations 
for the forward and reverse reactions, in 100 mM potassium phosphate buffer (pH 7.4) in 
a 96-well plate. L-malate, NAD+, oxaloacetate (OAA) and NADH concentrations were 
varied from zero to 3 mM, 4 mM, 0.1 mM and 0.1 mM, respectively. NADH 
concentration was measured spectrophotomerically at 340 nm after the addition of 1 nM 
and 0.1 nM mMDH for the forward and reverse reactions, respectively. CS activity was 
determined in 100 mM potassium phosphate buffer (pH 7.4) as well, via monitoring the 
coenzyme A (CoA) production at 412 nm in the presence of 0.2 mM DTNB (5,5’-
dithiobis(2-nitrobenzoate)) with 1 nM of enzyme in a 96-well plate. OAA and acetyl 
coenzyme A (acetyl-CoA) concentrations were varied from zero to 0.5 mM and 0.2 mM, 
respectively. NADH production/consumption was calculated using the extinction 
coefficient 6220 M-1cm-1. Production of citrate can be spectrophotometrically monitored 
through a subsequent reaction of CoA and DTNB, which yields a di-anion (TNB2-) 
absorbing at 412 nm. Citrate production rate was determined from the maximum linear 
slope of the curve of absorbance over time. Extinction coefficient of TNB2- at 412 nm 
was 14150 M-1cm-1 and the light path length was 0.56 cm. All enzyme concentrations 
were determined by BCA assay following the protocol provided by the manufacturer and 
a SpectraMax M2 (Molecular Devices) was used for absorbance readings. Obtained data 
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were fitted into the following ordered bi-bi equation in order to calculate the kinetic 
parameters of the enzymes: 
 
                            ! = !!"# ! [!]!!"!!!!! ! !!! ! ! ! [!]                                    [2.1]           
 
2.3.3.2 Coupled activity assays of the mMDH-CS complex in solution  
Equal amounts of mMDH and CS were mixed in 10 mM PBS (pH 7.4) to a final total 
protein concentration of 20 µM and incubated under gentle shaking at room temperature 
for 30 min. The coupled activity of the mMDH-CS complex (100 nM) or the crude lysate 
(0.5 mg/mL) was assayed in a 96-well plate with 1 mM L-malate, 2 mM NAD+, 0.1 mM 
acetyl coenzyme A, 0.2 mM DTNB and 10 mM glutamate in 200 µL of 100 mM 
potassium phosphate buffer (pH 7.4) in the presence of 1 or 5 U mL-1 aspartate 
aminotransferase (AAT). Control experiments were done without adding AAT. Glycerol 
was added to the enzyme and substrate solutions to 10 % and 20 % (v/v) prior to mixing. 
Then the coupled activity of the mMDH-CS complex (100 nM) or the crude lysate (0.5 
mg/mL) was assayed in a 96-well plate with 1 mM L-malate, 2 mM NAD+, 0.1 mM 
acetyl-CoA and 0.2 mM DTNB in 200 µL of 100 mM potassium phosphate buffer (pH 
7.4). Control experiments were done without adding glycerol. The absorbance increase at 
412 nm was monitored by SynergyTM HTX multi-mode microplate reader (BioTek) over 
1 min at 1 s intervals. One unit (U) of enzyme activity was defined as 1 µmole of product 
formed in one minute. 
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2.3.3.3 Coupled activity assay of immobilized mMDH-CS complex  
The mMDH-CS complex solutions (4 µM) and ala-chitosan solution (10 mg/mL) were 
mixed at a volume ratio of 2:1 and incubated on vortex at room temperature for 15 min. 
Cross-linked samples were prepared by incubating mixtures of mMDH and CS at 20 µM 
with 0.2 mM DSG under gentle shaking at room temperature for 30 min, followed by 
quenching with 2 M Tris (pH 8.3). The cross-linking ratio of DSG:protein was lowered to 
10:1 to minimize potential deactivation of enzymes by excessive cross-linkers. 25 µL of 
the enzyme/polymer suspension was pipetted to the bottom of a polystyrene cuvette (1 
cm for light path length) and dried in a vacuum at room temperature for 2 h. Coupled 
activity of immobilized enzyme complex was assayed in 1 mL of 100 mM potassium 
phosphate buffer (pH 7.4) containing 1 mM L-malate, 2 mM NAD+, 0.1 mM acetyl-CoA, 
0.2 mM DTNB, 10 mM glutamate and AAT at 0 or 1 U mL-1. The absorbance change at 
412 nm was monitored by a UV-Vis spectrophotometer (Evolution 260 Bio, Thermo 
Scientific).  
 
2.3.3.4 Transient time measurement  
Fast kinetic experiment was carried out in a 96-well plate measured by the plate reader 
equipped with a dual injection module. Before assays, 10 µL of mMDH (20 µM) and 10 
µL of CS (20 µM) were mixed in 10 mM PBS (pH 7.4) and incubated under gentle 
shaking at room temperature for 30 min, followed by dilution to 2 mL in 100 mM 
potassium phosphate buffer (pH 7.4). The crude lysate was directly used without further 
dilution. Substrate solution was prepared in 2 mL of potassium phosphate buffer 
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containing 2 mM L-malate, 4 mM NAD+, 0.2 mM acetyl-CoA and 0.4 mM DTNB. To 
setup the assay condition, enzyme and substrate solutions were respectively injected by 
two separate syringes at a flow rate of 250 µL s-1. Total assay volume was 200 µL s-1 per 
well. Absorbance at 412 nm was read every 90 ms over 1 min. Transient time of OAA 
was determined by extrapolating the linear line fitted to the absorbance curve within the 
first recorded 5 s. 
 
2.3.3.5 Predicted transient time calculations 
In addition to the experimental fast kinetic study of mMDH-CS complex, transient time 
analysis was performed using the experimentally obtained kinetic parameters of 
individual recombinant mMDH, recombinant CS and mutant CS(R65A). In Matlab, a 
function “xprime” is defined as the change in substrate / product concentrations with 
respect to time and the “ode45” function is used to solve the differential equations 
describing these substrate (OAA and acetyl-CoA) consumptions / product (citrate and 
CoA) formations. Obtained data are fitted using Excel and transient time of OAA was 
determined by extrapolating the linear line fitted to the time vs. product concentration 
plot. The Matlab code is given below: 
 







where x(1) is OAA and x(2) is acetyl-CoA. 
 
2.3.3.6 Elasticity coefficient calculations 
In order to calculate the elasticity coefficient of CS with respect to OAA, the following 
equation was used:30 
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where v is the reaction rate of CS and [OAA] is the concentration of substrate OAA. After 
taking the derivative of the rate equation with respect to OAA, kinetic parameters and 
steady state OAA concentration belonging to CS and CS(R65A) are fitted to Eq. 2.1, in 
order to obtain the steady state elasticity coefficients.31  
 
2.4 Results 
2.4.1 Recombinant TCA cycle enzymes  
The mMDH and CS enzymes function as dimers composed of identical subunits, 
weighing 34 kDa and 49 kDa respectively, whereas Aco (85 kDa) operates as a 
monomer. mMDH catalyzes the reversible NAD(H)-dependent conversion of L-malate 
and oxaloacetate (OAA). CS converts OAA and acetyl coenzyme A (acetyl-CoA) to 
citrate and Coenzyme A (CoA).  Aco follows CS in the TCA cycle and catalyzes the 
dehydration-rehydration of citrate to iso-citrate, with cis-aconitate being the 
intermediate.32, 33 These three consecutive enzymes from the TCA cycle have been 
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individually characterized, with porcine heart enzymes being the most extensively 
studied variants, which share 98 %, 96 % and 98 % sequence homology with bovine 
heart enzymes, for mMDH, CS and Aco, respectively. Here, three different enzyme 
groups were investigated: native enzymes isolated from the intact bovine mitochondria, 
commercially available wild-type enzymes and recombinantly produced enzymes.  
Codon optimized synthetic genes coding for porcine heart mMDH, CS and Aco were 
expressed in E. coli following previously reported protocols with slight variations in 
expression plasmids and culture media.17 After purification involving immobilized metal 
ion affinity chromatography and ion exchange chromatography, enzymes of > 90 % 
purity were obtained, as shown in Figure S2.1. The protein yields were 5 mg/L, 75 mg/L, 
50 mg/L, for mMDH, CS and Aco, respectively.  
 
2.4.2 Recombinant metabolons assembled in vitro  
In vitro chemical cross-linking of protein-protein interactions between recombinant 
mMDH and CS was performed in the presence of Aco to enable the formation of the 
native metabolon. SDS-PAGE analysis of commercial and recombinant enzyme mixtures 
demonstrated the formation of higher-ordered complexes by mMDH, CS and Aco after 
incubation with DSG, indicated by a set of intense bands above 100 kDa (Fig. S2.2), 
which might be the result of an assembly of mMDH, CS and Aco, or enzyme 
oligomerization. In-gel protein digestion by trypsin was conducted on large complex 
bands and the extracted peptide fragments were analyzed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS). Matching experimentally detected tryptic 
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peptides to protein databases using the Mascot search engine identified all of the three 
enzymes in both cross-linked and non-cross-linked sample bands (Table S2.2).  
Cross-linked peptide candidates were determined by comparing cross-linked and 
non-cross-linked mass spectra and matching additional masses after cross-linking to a 
manually-built theoretical mass database. Using the distance restraint (25 Å) on 
potentially DSG-linked residues (Fig. S2.3), a hybrid protein docking method was 
utilized to elucidate the interactions between wild-type mMDH and CS in vitro (ESI). As 
shown in Figure S2.4, a number of structures were found to meet the selection criteria 
and bear at least three identified cross-links. These structures exhibited distinct 
conformations, implying that mMDH and CS without any modifications interact in a 
random manner in dilute solution. Compared to the native tissue mitochondrial TCA 
cycle metabolon (Fig. 2.1A), one model of the complex of commercial mMDH-CS 
showed up with the most structural similarity. In this structure (Fig. 2.1B), three DSG 
cross-links (matching three MS speaks, Table S2.3) were obtained between mMDH Lys 
191, Lys 277, Lys 283 and CS Lys 325 (Table S2.4). The α- helices of CS at Ala1-His 28 
and Ser426-Lys437 are buried in the interface that covers the inter-subunit domain of 
mMDH. Compared to the native tissue mitochondrial metabolon in vivo, however, 
mMDH is flipped around the axis parallel to the binding interface by about 180 degrees. 
As a result, the two N-termini of mMDH are in close proximity with CS while the C-
termini are pointing outward. This flipping might not be favorable for facilitated transport 
or channeling of OAA, because mMDH active site clefts are now open to the bulk phase 
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and separated from CS active sites by a longer distance (73 Å) than that in the native 
tissue mitochondrial metabolon (35 Å).27  
In contrast to the complexes of commercial enzymes, the recombinant enzymes 
formed a unique structure bearing seven DSG cross-links (matching four MS peaks, 
Table S2.4) between mMDH Lys81, Lys217, Lys304, Lys305 and CS Lys76, Lys325, 
Lys432. The α-helices of CS near its N- and C-termini again participate in forming the 
binding interface with the inter-subunit region of mMDH. Although mMDH rotates 
around the axis perpendicular to the interface by approximately 30 degrees as compared 
to the metabolon in vivo, the final structure maintains most of the natural features (Fig. 
2.1C). No termini are buried in the interface, possibly due to spatial hindrance from 
additional amino acid appended to the termini, but the relative locations of termini around 
the interface are not significantly altered. The two N-termini of mMDH point away from 
CS and mMDH and CS active sites are brought within a closer proximity (40 Å) than 
what was observed in the complexes of commercial mMDH-CS (73 Å). In addition, the 
interfacial areas in the recombinant mMDH-CS complexes are about 12,100 Å2, 
suggesting that they may be more thermodynamically stable than either the native tissue 







Figure 2.1 Structures of the mMDH-CS complex and the simulated electrostatic 
potential on the surface of the complex. (A) Native tissue mitochondrial metabolon. (B) 
In vitro complex formed by commercial enzymes. (C) In vitro complex formed by 
recombinant enzymes. N- and C-termini are represented by red and blue spheres, 
respectively. FLAG-tag and polyhistidine-tag are represented by red and blue sticks, 
respectively. mMDH and CS active sites are denoted by black arrows. (D) In vitro 
complex formed by commercial enzymes. (E) In vitro complex formed by recombinant 
enzymes. Surface regions of positive potential and negative potential are colored in blue 
and red, respectively. The electrostatic channeling path for OAA is highlighted by the 
yellow edge. Orange arrows indicate the active sites. The surface electrostatic potential 
(ESP) was calculated with water molecules at pH 7.4. 
Formation of the mMDH-CS-Aco complexes in vitro was also examined by 
docking commercial or recombinant Aco onto solved mMDH-CS complexes. Figure S2.5 
shows the simulated structures of the commercial and recombinant mMDH-CS-Aco 
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complexes in dilute solution. Three DSG cross-links (matching three MS peaks) were 
identified between CS Lys16, Lys76, Lys80 and Aco Lys4, Lys117 in the tri-enzyme 
complex formed by commercial enzymes (Table S2.5). It was found that CS Lys76 and 
Lys80 were located in the mMDH-CS interface, implying that mMDH and Aco would 
not be present on the same subunit of CS. Therefore, each CS dimer can only bind one 
mMDH dimer and one Aco monomer (Fig. S2.5A). In the recombinant mMDH-CS-Aco 
complexes, there were four DSG cross-links between CS Lys294, Lys300 and Aco 
Lys709, Lys712, exhibiting no conflict with the identified cross-links between mMDH 
and CS, although only one MS peak was matched (Table S2.6). This result is consistent 
with the one obtained from in vivo cross-linking of CS and Aco. Residues within C-
terminal region of the recombinant Aco were recognized at the CS-Aco interface. A 
groove formed between mMDH and CS appeared to accommodate the C-terminus of Aco 
(Fig. S2.5B). Hence, the resulted tri-enzyme association was found to be more compact 
than that of the metabolon formed by commercial mMDH and CS. Similarly to the native 
tissue mitochondrial metabolon, a recombinant octamer comprised of one CS dimer, two 
mMDH dimers and two Aco monomers could possibly form in vitro.27  
Simulation of the three-enzyme system was built on the assumption that inclusion 
of Aco does not alter the complex formation between mMDH and CS. The interaction 
between Aco and CS (or mMDH) is much weaker than that between mMDH and CS 
according to previous observations in vivo, even though there is a lower chance that CS 
(or mMDH) binds Aco prior to mMDH (or CS) in dilute solution. Therefore, the 
contribution of Aco to the structural assignment between mMDH and CS was taken as 
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trivial in our case and the rest of the experimental efforts were focused on the 
investigation of the channeling of OAA within the mMDH-CS complex which is 
consistent with most of the related research in the literature.17, 19 
 
2.4.3 Simulated electrostatic channeling in wild-type/recombinant complexes  
To further investigate electrostatic channeling in the mMDH-CS complex formed in 
vitro, the electrostatic surface potential was examined using the Poisson-Boltzmann 
equation in the presence of water molecules at pH 7.4. As illustrated in Figure 2.1D, a 
long and broad band of positive potential covers the majority of the complex surface of 
the commercial enzymes on one side, connecting the active sites. In the recombinant 
mMDH-CS complex (Fig. 2.1E), the positive patch connecting active sites was greatly 
reduced due to their shortened separation as well as relative orientation. Together with 
previous results from simulation of surface ESP of free enzymes, formation of substrate 
channeling in such dynamic complexes is a product of electrostatic protein-protein 
interactions and rearrangement of surface charges upon association. Charged surface 
residues, especially positively charged arginines and lysines, may play an essential role in 
directed transport of negatively charged OAA.  
 In order to explore the importance of positively charged residues for the 
electropositive channel between mMDH and CS, interfacial residues of the recombinant 
complex were identified by screening surface arginines and lysines within a distance of 
20 Å from each other. As a result, CS arginines (R) at positions 65 and 67 were estimated 
to be important for the formation of the positive channel on the surface of the complex. 
37 
!
Site-directed mutagenesis was performed at these positions and six different CS mutants 
were explored, where the arginines were replaced either by alanine or aspartic acid: 
R65A, R67A, R65A/R67A, R65D, R67D and R65D/R67D. The arginine at position 67 
was found to be crucial for the enzymatic activity of the recombinant CS.  Mutation of 
this residue to alanine or aspartate either decreased or eliminated the enzymatic activity 
(Table S2.7). CS(R67A), CS(R65A/R67A), and CS(R65D) exhibited 2 or 3 orders of 
magnitude reductions of specific activities in comparison to the recombinant wild-type 
CS. CS(R67D) and CS(R65D/R67D) enzymatic activities could not be determined. In 
addition, CS(R67D) and CS(R65D/R67D) were found to be structurally affected by the 
mutations as shown in Figure S2.6. CS(R65A) was the only mutant with similar kinetic 
activity as compared to the wild-type recombinant CS (Table 2.1). The mutation of the 
arginine residue of CS at position 65 to alanine resulted in the dissociation of the 
mMDH-CS complex as implied by the disappearance of the mMDH-CS complex band in 











Table 2.1 Kinetic parameters of recombinant enzymes.a  
 
Enzyme kcat (s-1) Ki, A (mM)b KM, A (mM)b KM, B (mM)c 
mMDH, fwd 31 ± 2 0.42 ± 0.08 0.13 ± 0.03 0.83 ± 0.10 
mMDH, rev 870 ± 140 15 ± 2 87 ± 22 33 ± 7.9 
CS 88 ± 4 4.6 ± 0.8 7.9 ± 1.2 21 ± 3 
CS(R65A) 44 ± 3 1.7 ± 0.1 1.1 ± 0.3 7.8 ± 2.3 
 
a Data are given as mean values ± SD from at least three independent measurements.  
b Substrate A is NAD+ for mMDH, fwd, NADH for mMDH, rev and OAA for both CS 
and CS(R65A). 
c Substrate B is L-malate for mMDH, fwd, OAA for mMDH, rev and acetyl-CoA for both 
CS and CS(R65A).  
 
2.4.4 Electrostatic channeling of OAA in the presence of a competing enzyme and in 
viscous solutions  
One of the common methods to experimentally probe substrate channeling is to introduce 
a second enzyme competing for the same intermediate.34 As illustrated in Figure 2.2A, 
the mMDH-CS complex catalyzes sequential conversion of L-malate to citrate via OAA 
as the intermediate, using NAD+ and acetyl-CoA as cofactors. To investigate the 
electrostatic channeling in the recombinant mMDH-CS complex, a competitive pathway 
experiment was conducted with aspartate aminotransferase (AAT), which catalyzes the 
reversible conversion of OAA and L-glutamate to aspartate and α-ketoglutarate. In the 
presence of AAT, the resultant citrate generation rate measured with crude lysate 
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containing the native tissue mitochondrial mMDH-CS complex showed little change 
(Fig. 2.2B). Approximately 87 % of the recombinant mMDH-CS activity was retained, 
whereas 70 % of the commercial mMDH-CS activity was retained in the presence of 1 U 
mL-1 of AAT.  As the AAT concentration increased to 5 U mL-1, 89 %, 77 % and 67 % of 
the coupled activity remained in the native tissue mitochondrial, recombinant complexes 
and the complex of commercial enzymes, respectively (Fig. 2.2B). 
To minimize potential mMDH-AAT interactions, coupled catalysis was also 
explored with complexes immobilized in modified chitosan polymers. This ensured that 
AAT was physically separated from the complex and could not interact with the 
metabolon. Similar results were obtained compared to the free complexes in solution. As 
shown in Figure S2.8, retained coupled activity of immobilized complexes formed by 
commercial and recombinant enzymes are 70 % and 84 %, respectively. After cross-
linking of the recombinant mMDH-CS complex during immobilization, the retained 
coupled activity of the recombinant mDH-CS complex was increased to 97 % when 1 U 
mL-1 AAT was present. On the contrary, cross-linking of commercial enzymes reduced 
their retained coupled activity to 49 %. In the case of CS(R65A) mutant, coupled activity 
was reduced to about 36 % of the original recombinant complex. Competing pathway 
experiments were performed with the mMDH-CS(R65A), mutant recombinant complex, 
as well and only 50 % of citrate production was retained in the presence of 5 U mL-1 
AAT after the mutation. 
Glycerol was added into the assay solution to simulate the viscous matrix in vivo 
and the efficiency of mass transport in different mMDH-CS complexes were compared. 
40 
!
As Figure 2.2C demonstrates, coupled activity of the native tissue mitochondrial mMDH-
CS complex in crude lysate was not affected by the increased viscosity. For the 
recombinant complex, sequential catalysis stayed almost unchanged at 10 % glycerol, but 
decreased by 16 % in 20 % glycerol. This indicates that substrate channeling in the 
artificial complex functions in a “leaky” fashion, meaning that not all intermediates are 
channeled. When compared to the complex of commercial enzymes and the mutant 
recombinant complex (mMDH-CS(R65A)), which respectively lost 15 % and 20 % of 
coupled activity in 10 % glycerol, and 30 % and 35 % of coupled activity in 20 % 
glycerol, the recombinant complex (mMDH-CS) was less affected by increases in 































Figure 2.2 Demonstration of channeling of OAA within the mMDH-CS complex. (A) 
Schematic of the coupled mMDH-CS catalysis in the presence of competing enzyme 
AAT. White and black arrows represent diffusion and directed channeling, respectively. 
Crystal structure of AAT is obtained from Protein Data Bank (PDB: 1AAT). (B) Coupled 
activity retention calculated as the ratio of reaction rate before and after adding AAT 
measured with 100 µM mMDH-CS complex or crude mitochondrial lysate (about 5 µM 
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protein in total). (C) Coupled activity retention in the presence of glycerol. Error bars 
represent standard deviation calculated from three independent experiments. Statistical 
significance (p-value) with respect to samples without AAT was calculated by a two-
sample t-test with Welch correction for unequal variances: * = p < 0.05, ** = p < 0.01. 
 
2.4.5 Kinetic analysis of recombinant mMDH, CS and CS mutants  
The steady state kinetics of the recombinant mMDH, recombinant CS and mutant CS 
enzymes were evaluated. Both mMDH and CS follow the ordered bi-bi kinetic 
mechanism, where mMDH binds to its cofactor and CS binds to OAA first.35, 36 MDH 
kinetics was obtained by varying L-malate, NAD+, OAA and NADH concentrations from 
zero to 3 mM, 4 mM, 0.1 mM and 0.1 mM, respectively. For CS, OAA and acetyl-CoA 
concentrations were varied from zero to 0.5 mM and 0.2 mM. The full steady state 
kinetic parameters are reported in Table 2.1. Recombinant CS had a kcat/KM,acetyl-CoA value 
of  4.3 µM-1s-1 and kcat/KM,OAA value of and 11.2 µM-1s-1 whereas CS(R65A) had a 
kcat/KM,acetyl-CoA value of  5.6 µM-1s-1 and a kcat/KM,OAA value of 38.8 µM-1s-1. These 
indicate that R65A mutation did not impair the kinetics of the enzyme. Specific activities 
of the CS mutants are given in Table S2.7 in addition to their relative specific activities 
compared to recombinant wild-type CS. CS and CS(R65A) had similar enzymatic 
activities whereas CS(R67A), CS(R65A/R67A), CS(R65D) exhibited two or three orders 
of magnitude reduction of specific activities in comparison to the recombinant wild-type 
CS; and CS(R67D) and CS(R65D/R67D) enzymatic activities could not be determined 
due to severely impaired kinetics (Table 2.1, Table S2.7). 
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2.4.6 Characterization of electrostatic channeling by transient-time analysis 
Transient time (τ) is used to describe the lifetime of intermediates in coupled catalysis. In 
unassembled systems where enzymes are not interacting, intermediate species will spend 
more time travelling to the next active site, thus resulting in longer observed transient 
times before steady state activities are reached. Substrate channeling enabled by 
electrostatic pathways between active sites in metabolons can result in decreased 
intermediate lifetimes.37 Here, the ordered bi-bi enzymatic mechanisms were treated as 
pseudo first-order coupled reactions by keeping sufficient concentrations of cofactors in 
the system. The overall initial reaction rates were limited by the OAA transport between 
mMDH and CS, which is also highly dependent on the diffusion coefficient (Di) of 
intermediates and the diffusing length (l) between active sites. Assuming that diffusion 
coefficients of OAA in all examined systems were not considerably altered, the transient 
time of OAA would be closely related to the diffusion distance length between the 
mMDH and CS active sites.  
The transient time of OAA was measured in the native tissue mitochondrial 
metabolon, metabolons formed by commercial, recombinant and mutant mMDH and CS 
(Fig. 2.3, Table 2.2). The simulated electrostatic channeling pathway (40 Å) for OAA 
was shorter in the mMDH-CS complex formed by recombinant enzymes, compared to 
commercial enzymes (73 Å). Consequently, the transient time of OAA in the 
recombinant complex was measured to be 30 ± 11 ms, which is comparable to the value 
of 40 ± 5 ms measured with crude lysate containing the native tissue mitochondrial TCA 
cycle metabolon. In comparison, the transient time of OAA in the complex of 
44 
!
commercial enzymes was almost one order of magnitude higher, with a value of 293 ± 35 
ms. In the case of the mutant mMDH-CS(R65A) complex, the resultant transient time 
was increased to 882 ± 57 ms, approaching 1 s.  According to these results, the 
channeling of OAA was fastest in the native tissue mitochondrial complex followed by 
the recombinant complex, complex of commercial enzymes and the mutant mMDH-
CS(R65A) complex, respectively. 
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Figure 2.3 Characterization of OAA channeling via transient-time analysis. Citrate 
production was measured over time. Transient time predictions of recombinant and 
mutant complexes were determined using the kinetic rate equations. Transient time for 
each enzyme sample was determined by extrapolating the linear line fitted to the curve to 




Table 2.2 Measured and predicted transient times of OAA.a 
 
Sample τ  (ms) 
Native Tissue 40 ± 5 
Commercial 293 ± 35 
Recombinant 30 ± 11 
Mutant 882 ± 57 
Predicted Recombinant 2500 
Predicted Mutant 900 
 
a Transient times were determined from linear fits from Figure 2.3. Mean and standard 
deviation for experimental values were calculated from three independent experiments. 
 
2.5 Discussion 
The interplay between mass transfer and kinetics has driven substantial interest in 
metabolon formation and substrate channeling that is thought to occur in many biological 
cascade reactions. The TCA cycle enzymes are a canonical example of this process and 
thus have been extensively investigated by various research groups. Channeling of OAA 
between the last (mMDH) and the first (CS) enzymes of the cycle has been studied in 
particular. Characterizing the leaky channeling within this system has been difficult due 
to limited experimental tools. In this work, we present direct evidence for metabolon 
formation among recombinant TCA enzymes and we were able to more directly 
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investigate the substrate channeling within native and engineered mMDH-CS complexes 
via site-directed mutagenesis.  
 In the mitochondrial matrix, compartmentalized TCA cycle enzymes diffuse 
slowly and their dynamic association is stabilized by the crowded environment. On the 
contrary, the apparent diffusion coefficient of enzymes in dilute solution is approximately 
two orders of magnitude higher and the molecular collision occurs much faster.11, 38-41 
Any transient interactions may be captured by covalent conjugation, thus complicating 
the entity of all possible structures. In vitro chemical cross-linking, mass spectrometric 
analysis and protein docking were utilized to map the interacting residues to determine 
the structure of the mMDH-CS-Aco complex. The observed interactions between 
mMDH, CS and Aco turned out to be strong enough to maintain the association even at 
relatively low protein concentrations (2 mg/mL). In contrast to the random association of 
commercial enzymes that yielded a number of complex conformations with some 
disfavoring direct OAA transport, the recombinant enzymes in dilute solution appeared to 
interact in a more restricted way that resulted in a unique complex conformation favoring 
OAA channeling. Moreover, active site separation in the recombinant complex was 
measured to be 33 Å shorter than that measured in the complex of commercial enzymes 
and the recombinant complex may be more thermodynamically stable in vitro with a 
larger binding interface area of 12,100 Å2. With this shorter pathway, OAA transfer was 
expected to be faster than that in the wild-type complex. 
Substrate channeling between mMDH and CS was demonstrated via numerical 
simulations, competing enzyme experiments and transient time analyses. With Brownian 
47 
!
dynamics simulations, Elcock and McCammon demonstrated that inclusion of 
electrostatic forces at the surface of a yeast mMDH-CS fusion protein greatly improved 
the OAA transfer efficiency to 45 %, which was less than 1 % in the absence of 
electrostatic forces.19, 42 In their fusion protein, a continuous surface of positive 
electrostatic potential connected mMDH and CS active sites separated by 60 Å, implying 
the potentially important role of surface charge distribution in electrostatically directed 
transport of OAA.15 In the natural TCA cycle metabolon, theoretical evidence for 
electrostatic channeling was also found between mMDH and CS active sites using 
simulation tools.27  
In this work, the surface ESP of each mMDH-CS complex was calculated and it 
was shown that an electrostatic channeling path, bridging active sites, forms at the 
surface of commercial as well as recombinant enzymes. However, the recombinant 
complex with its active sites closely facing each other provides a channeling advantage 
over the complex of commercial enzymes whose active sites are further apart and facing 
oppositely. This has been confirmed by a competitive pathway assay at different 
conditions. In a non-channeling system, OAA escaping into the bulk phase would be 
consumed by AAT, thus reducing the coupled mMDH-CS activity and the production of 
citrate. If OAA is directly channeled at the enzyme surface, the coupled catalysis would 
not be affected by the presence of AAT. We showed that coupled production of citrate by 
the recombinant complex was significantly less affected by the presence of a competing 
enzyme (AAT) or a viscous reagent (glycerol). Taken together, these results demonstrate 
that assembly of sequential enzymes is of importance to efficient substrate channeling in 
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an unfavorable environment. Moreover, we performed a mutagenesis study in the 
recombinant system and studied the complex formation in the presence of a mutated 
version of CS, in addition to the complex of commercial mMDH, CS and recombinant 
mMDH-CS complex. Site-directed mutation of arginine at position 65 to alanine along 
the positively charged patch connecting the active sites, disrupted the transport of the 
negatively charged intermediate. Mutated recombinant complex retained only 50 % of 
citrate production in the presence of 5 U mL-1 AAT demonstrating that intermediate 
transport in the mMDH-CS(R65A) is more prone to being interrupted by competing 
pathways. 
Transient-time analysis also demonstrated that the mMDH-CS complex formed 
by recombinant enzymes in solution achieved similar channeling characteristics as the 
native tissue mitochondrial metabolon. The transient time of OAA in the recombinant 
mMDH-CS complex was reduced by 90 % compared to the complex of commercial 
enzymes, indicating a higher efficiency of mass transport and reaction coupling. It was 
noted that reduction of transient time in the recombinant complex, as compared to 
complex of commercial enzymes, was larger than the expected value of 70 %, according 
to the equation for one-dimensional random walk, l2 = 2Di.43 The most plausible reason 
would still be that the active sites are facing directly each other in the recombinant 
complex. In the complex of commercial enzymes, however, the active site clefts in 
mMDH are facing oppositely to CS and are open to the bulk phase, resulting in a higher 
chance of OAA escaping from the vicinity of enzymes once released from mMDH active 
sites. Although substrate channeling in both systems was found to be “leaky” through 
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assays with AAT and glycerol, it is evident that recombinant enzymes exhibit higher 
catalysis coupling efficiency.  
An analytical approach has previously been developed, which relates the substrate 
channeling phenomena to the Michaelis-Menten parameters of the enzymes.37, 42, 44 
According to this correlation, a channeling probability parameter, defined as pc pr, can be 
obtained using the transient time, KM and Vmax of the second enzyme in the complex. The 
equation applicable to the mMDH-CS system is defined as the following:42 
                                ! = !!!,!"",!""!(!!!!!!)!!"#,!""                                                  [2.3] 
 By using the ordered bi-bi rate equation and the kinetic parameters of the 
recombinant mMDH, CS and CS(R65A), simulated citrate formation by unassembled 
enzymes was plotted with respect to time (Fig. 2.3). From this prediction, the transient 
times of OAA in recombinant mMDH-CS and mMDH-CS(R65A) systems were 
estimated to be 2.5 s and 0.90 s, respectively (Table 2.2). These values represent the 
transient times if the two enzymes were not interacting with each other. No substrate 
channeling should be expected, thus the probability parameter, pc pr, can be taken to be 
equal to 0. As shown by Eq. 2.1, KM,app/Vmax,app  is equal to the transient time in the case 
of no channeling. When this KM,app/Vmax,app  parameter is used together with the transient 
times obtained in case of the complexes formed by the enzymes (0.03 s and 0.882 s for 
the recombinant and mutant complexes respectively), the combined channeling 




This analysis provides further proof that the channel formation is disrupted in the 
mutant mMDH-CS(R65A) complex. The predicted and measured transient times are very 
similar for mMDH-CS(R65A) (0.903 s vs 0.882 s), which indicates that the intermediate 
OAA is channeling very poorly after the mutation of CS at position 65. On the contrary, 
the measured time lag for the recombinant complex was 0.03 s, which is significantly 
different than the predicted one, indicating the channeling of OAA within the metabolon. 
The probability parameter, should pc pr, approach 1 as intermediates are efficiently 
channeled in a dual enzyme system.42 This value was found to be 0.988 for mMDH-CS 
and 0.023 for mMDH-CS(R65A), demonstrating the decrease in the channeling 
efficiency after the mutation. A comparison of the kcat/KM,acetyl-CoA values for the 
recombinant wild-type (4.3 µM-1s-1) and mutant CS (5.6 µM-1s-1) as well as the 
kcat/KM,OAA values (11.2 µM-1 s-1 for wild-type and 38.8 M-1 s-1 for the mutant CS) indicate 
that these results arise from changes in the transport efficiency of the complexes and are 
not due to major changes in kinetic activities.    
Prior mutational studies of CS have involved the active site residues, aiming for 
the improvement of enzyme catalysis,45-48 while the two residues mutated in this work are 
not located near the active site (Fig. S2.9, Table S2.8). These corresponding residues at 
the 65th and 67th positions were compared among different species and it appears that 
R67 is highly conserved whereas R65 is generally well conserved with a few species 
having different amino acids at this position, suggesting the importance of positive 
charge at these positions (Table S2.9).  
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Metabolic Control Analysis (MCA) provides a framework to understand how 
metabolic fluxes are regulated by enzymatic activities.31, 49 The TCA cycle is a highly 
regulated network in central metabolism. In order to further investigate the potential 
implications of the R65A mutation, the elasticity coefficients of CS and CS(R65A) with 
respect to substrate OAA were estimated to be 0.79 and 0.63 (Eq. 2.2), respectively, 
based on the steady-state substrate concentrations obtained with our model. Thus, the 
sensitivity of CS to OAA concentrations was substantially decreased by the mutation. 
Taking the connectivity theorem into account, it can be concluded that this mutation 
would lead to an increased flux control coefficient indicating a potentially increased role 
in regulating metabolic control. The potential impact on the flux control may explain why 













2.6 Supplementary Information  
2.6.1 Supplementary Figures 
                                             
Figure S2.1 SDS-PAGE analysis of recombinant enzymes. (1) Protein ladder. (2) 








Figure S2.2 SDS-PAGE analysis of cross-linked and non-cross-linked (control) 
mMDH-CS complexes in vitro for commercial and recombinant enzymes. (a) 
Commercial mMDH subunit. (b) Commercial CS subunit. (c) Commercial mMDH-CS 
complex. (d) Recombinant mMDH subunit. (e) Recombinant CS subunit. (f) 
Recombinant mMDH-CS complex. Gel bands of interest for subsequent digestion and 








Figure S2.3 Summary of all possibly cross-linked lysine residues. (represented by K) 
(A) in the in vitro mMDH-CS complex formed by commercially available enzymes. (B) 
in the in vitro mMDH-CS complex formed by recombinant enzymes. (C) in the in vivo 









Figure S2.4 mMDH-CS metabolon structures. All possible complex structures formed 
by commercial mMDH (colored in sky blue and cyan) and CS (colored in gold and 
yellow) in solution. The crystal structure of mMDH and CS were obtained from the 
Protein Data Bank (PDB: 1MLD and 1CTS). The structure with the most similarity to the 








Figure S2.5 mMDH-CS-Aco complex structures. (A) Structures of the complex of 
commercial enzymes and (B) recombinant mMDH-CS-Aco complex formed in vitro. The 
crystal structure of Aco, mMDH and CS were obtained from the Protein Data Bank 
(PDB: 1MLD, 1CTS and 7ACN). Aco is colored in purple. FLAG-tagged N-terminus 










Figure S2.6 Protein gel pictures of CS mutants. (A) SDS-PAGE analysis: (1) Protein 
ladder. (2) recombinant CS. (3) CS(R65A). (4) CS(R67A). (5) CS(R65A/R67A). (6) 
CS(R65D). (7) CS(R67D). (8) CS(R65D/R67D).  All mutants have a molecular weight of 
49 kDa. (B) Native-PAGE analysis: (1) recombinant CS. (2) CS(R65A). (3) CS(R67A). 
(4) CS(R65A/R67A). (5) CS(R65D). (6) CS(R67D). (7) CS(R65D/R67D). (C) Blue 
Native-PAGE analysis: (1) Protein ladder. (2) recombinant CS. (3) CS(R65A). (4) 











Figure S2.7 Blue Native-PAGE analysis. (1) Recombinant mMDH-CS complex. (2) 
Recombinant mMDH-CS(R65D) complex. (3) Recombinant mMDH-CS(R67A) 
complex. (4) Recombinant mMDH-CS(R67D) complex. (5) Recombinant mMDH-
CS(R65A) complex. (6) Recombinant mMDH-CS(R65A/R67A) complex. (7) Protein 





                                  
Figure S2.8 Coupled activity retention of the immobilized mMDH-CS complexes. 
Enzymes were immobilized in Ala-chitosan. The assay was performed in the presence of 
1 U mL-1 AAT. Error bars represent standard deviation calculated from three independent 
experiments. Statistical significance (p-value) was calculated by a two-sample t-test with 












                                       
Figure S2.9 Mutation locations in CS. Structure of a porcine CS subunit (PDB: 1CTS). 
The residues shown in purple represent the mutation sites found in literature (Table 











2.6.2 Supplementary Tables 
Table S2.1 Primers used to perform site-directed mutagenesis on CS  
Mutation Primer Sequence 
CS(R65A) 
Forward 5’ CGGACGAAGGCATTGCTTTTCGCGGTTATTC 3’ 
Reverse 5’ GAATAACCGCGAAAAGCAATGCCTTCGTCCG 3’ 
CS(R67A) 
Forward 5’ GAAGGCATTCGTTTTGCCGGTTATTCGATCCC 3’ 
Reverse 5’ GGGATCGAATAACCGGCAAAACGAATGCCTTC 3’ 
CS(R65D) 
Forward 5’ CCGGACGAAGGCATTGATTTT CGCGGTTATTCG 3’ 
Reverse 5’ CGAATAACCGCGAAAATCAAT GCCTTCGTCCGG 3’ 
CS(R67D) 
Forward 5’ CGAAGGCATTCGTTTTGACGG TTATTCGATCCC 3’ 
Reverse 5’ GGGATCGAATAACCGTCAAA ACGAATGCCTTCG 3’ 
CS(R65A/
R67A) 
Forward 5’ GAAGGCATTGCTTTTGCCGGTTATTCGATCCC 3’ 
Reverse 5’ GGGATCGAATAACCGGCAAAA GCAATGCCT TC 3’ 
CS(R65D/6
7D) 
Forward 5’ CGAAGGCATTGATTTTGACGG TTATTCGATCCCG 3’ 








Table S2.2 Identified TCA cycle enzymes in the cross-linked and non-cross-linked 
protein bands (based on Mascot search results (mass tolerance: 5 ppm)). Same sequences 















mMDH 1598 162 32 67 % 
CS 893 63 17 25 % 
Aco 805 32 20 30 % 
 mMDH 782 172 12 44 % 
Cross-linked 
commercial CS 557 424 
10 22 % 
 Aco 97 3 2 3 % 
 mMDH 826 42 14 48 % 
Non-cross-linked 
recombinant CS 831 96 16 30 % 
 Aco 2672 197 56 52 % 
 mMDH 507 16 9 35 % 
Cross-linked 
recombinant CS 449 35 10 18 % 
 Aco 1223 69 26 32 % 
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Table S2.3 List of identified DSG cross-linked peptides from complexes of commercially 
purchased mMDH and CS 










M)QR 1136.2471 3405.7230 3405.7239 -0.26 
TIIPLISQCTPKVDFPQD
QLSTLTGR KTDPRYTCQR 1059.2951 4233.1512 4233.1561 -1.16 
 
Table S2.4 List of identified DSG cross-linked peptides in the recombinant mMDH-CS 
complex  




































Table S2.5 List of identified DSG cross-links of commercial Aco and CS peptides 
  !















KM(OX)LPKAK 954.2368 3812.9180 3812.9101 2.07 
 
 
Table S2.6 List of identified DSG cross-links of recombinant Aco and CS peptides 






















Table S2.7 Kinetic properties of recombinant CS mutants a 
Enzyme Enzyme Concentration (nM) Specific Activity (s
-1) Relative Specific Activity 
Recombinant CS 3 28.5 1.00 
CS(R65A) 3 24.5 0.86 
CS(R67A) 300 0.59 0.02 
CS(R65A/R67A) 3000 0.12 0.004 
CS(R65D) 300 0.24 0.008 
CS(R67D)      N/A 
CS(R65D/R67D)      N/A 
 
a The specific activities were measured in 50 mM Tris-HCl (pH 7.7) with 0.2 mM acetyl-
























Table S2.8 CS mutations found in literature 
Residue Mutations Location 
H235 a Q  
N242 a E  
H274 b G, R OAA / acetyl-CoA binding site 
G275 a A, V  
H320 a R, N, Q, G OAA binding site 
D327 a N  
D375 b N, Q, E, G acetyl-CoA binding site 
R401 a G, H, K OAA binding site 
 
a Evans, et al.45  












Table S2.9 Conservation of Arg65 and Arg67 in CS a 
Organism Sequence ID Match (%) Residue at Position 65 / 67 
Capitella teleta ELU15766.1 76 E / R 
Metaseiulus occidentalis XP_003739390.1 73 A / R 
Ixodes scapularis XP_002411280.1 73 A / R 
Sarcoptes scabiei KPM02928.1 73 S / R 
Limulus polyphemus XP_013775370.1 72 E / R 
Nematostella vectensis XP_001641037.1 72 E / R 
Stegodyphus mimosarum KFM64927.1 68 E / R 
Rhizophagus irregularis EXX70579.1 65 E / R 
a The data include the mismatches between CS Arg65 and Arg67 among the first 500 hits 
obtained via Basic Local Alignment Search Tool.50 Sequence identity varied between 64–











2.6.3 Supplementary Methods 
2.6.3.1 Structural analysis 
2.6.3.1.1 In vitro chemical cross-linking of mMDH, CS and Aco 
Commercially available enzymes purchased from Sigma-Adrich and recombinant 
enzymes were cleaned up by a pre-packed SephadexTM G-25M column (GE Healthcare) 
into 10 mM phosphate buffer (pH 7.4) to remove ammonium sulfate and other salts 
containing primary amine. Afterwards, mMDH, CS and Aco were mixed equally to a 
total protein concentration of 20 µM in 10 mM phosphate buffer (pH 7.4). DSG dissolved 
in 50 µL of DMF was added to the enzyme mixture to a final concentration of 1 mM. The 
approximate DSG/protein molar ratio was 50:1 to ensure an efficient capture of weak 
protein-protein interactions in dilute solution without dramatic loss of enzyme activity. 
As the non-cross-linked control, 50 µL of DMF containing no DSG was used. Cross-
linking was carried out at room temperature for 30 min under gentle shaking and 
quenched by adding 2 M Tris buffer (pH 8.3) to a final concentration of 20 mM. 
 
2.6.3.1.2 Separation and in-gel digestion of enzyme complexes  
Enzyme mixtures were washed with 50 mM Tris buffer (pH 7.4) in filter-incorporated 
Amicon tubes with a mass cutoff at 10 kDa at 5000 × g for 15 min to remove phosphates 
and extra DSG. Afterwards, cross-linked and non-cross-linked samples were directly 
separated by reducing SDS PAGE, which was performed on a 4–20 % gradient gel 
according to the protocol provided by the manufacturer. Gel bands of interest were 
excised and de-stained twice in 1 mL of 50 % methanol with 50 mM ammonium 
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bicarbonate at room temperature, under gentle vortexing for 1 h. The gel slices were 
rehydrated in 1 mL of 50 mM ammonium bicarbonate at room temperature for 30 min 
and the gel bands/spots of interest were cut into several pieces. These gel pieces were 
rehydrated in 1 mL of 100 % acetonitrile at room temperature under gentle shaking for 30 
min. Acetonitrile was carefully removed from the gel pieces with a pipette tip prior to 
trypsin digestion. The gel pieces were incubated with 10–20 µL of sequence-grade 
modified trypsin (20 ng/µL, Promega) in 50 mM ammonium bicarbonate overnight at 37 
°C. Digestion was quenched by adding 20 µL of 1 % formic acid. Then, the solution was 
allowed to stand and peptides that dissolved in the 1 % formic solution were extracted 
and collected.  
 Further extraction of peptides from the gel material was performed twice by 
adding 50 % acetonitrile with 1 % formic acid and sonicating at 37 °C for 20 min. All 
these solutions were collected and combined. A final complete dehydration of the gel 
pieces was accomplished by adding 20 µL of 100 % acetonitrile followed by incubation 
at 37 °C for 20 min. The combined supernatant solutions of extracted peptides were dried 
in a vacuum centrifuge (Speed-Vac). The peptides were reconstituted in 100 µL of 5 % 
acetonitrile with 0.1 % formic acid for mass spectrometric analysis. 
 
2.6.3.1.3 Mass spectrometric instrumentation 
Peptides were analyzed using a nano-liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) system comprised of a nano-LC pump (Eksigent) and a LTQ-FT mass 
spectrometer (ThermoElectron Corporation). The LTQ-FT is a hybrid mass spectrometer 
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with a linear ion trap used typically for MS/MS fragmentation (i.e. peptide sequence) and 
a Fourier transform ion-cyclotron resonance (FT-ICR) mass spectrometer used for 
primary accurate mass measurement of peptide ions. The LTQ-FT is equipped with a 
nanospray ion source (ThermoElectron Corporation). Approximately 5 to 20 fM of 
tryptic-digested or phosphopeptide-enriched samples were dissolved in 5 % acetonitrile 
with 0.1 % formic acid and injected onto a homemade C18 nanobore LC column for 
nano-LC-MS/MS. A linear gradient LC profile was used to separate and elute peptides, 
consisting of 5 to 70 % solvent B in 78 min with a flow rate of 350 nL min-1 (solvent A:    
5 % acetonitrile with 0.1 % formic acid; solvent B: 80 % acetonitrile with 0.1 % formic 
acid). The LTQ-FT mass spectrometer was operated in the data-dependent acquisition 
mode controlled by Xcalibur 1.4 software, in which the “top 10” most intense peaks 
observed in an FT primary scan (i.e. MS survey spectrum) were determined by the 
computer on-the-fly and each peak was subsequently trapped for MS/MS analysis and 
sequenced through peptide fragmentation by collision-induced dissociation. Spectra in 
the FT-ICR were acquired from m/z 400 to 1700 at 50000 resolving power with about 3 
ppm mass accuracy. The LTQ linear ion trap was operated with the following parameters: 
precursor activation time was 30 ms and activation Q was 0.25; collision energy was set 
at 35 %; dynamic exclusion width was set at low mass of 0.1 Da with one repeat count 






2.6.3.1.4 Mascot database searches 
LTQ-FT MS raw data files were processed to peak lists with BioworksBrowser 3.2 
software (ThermoElectron Corporation). Processing parameters used to generate peak 
lists were as followed: precursor mass was between 401–5500 Da; grouping was enabled 
to allow five intermediate MS/MS scans; precursor mass tolerance was set at 5 ppm; 
minimum ion count in MS/MS was set to 15 and minimum group count was set to 1. 
Resulting DTA files from each data acquisition were merged and searched against the 
NCBI or custom databases for identified proteins, using MASCOT search engine (Matrix 
Science Ltd; version 2.2.1; in-house licensed). Searches were done with tryptic 
specificity, allowing two missed cleavages or “non-specific cleavage” and a mass error 
tolerance of 5 ppm in MS spectra (i.e. FT-ICR data) and 0.5 Da for MS/MS ions (i.e. 
LTQ Linear ion trap). Identified peptides were generally accepted only when the 
MASCOT ion score value exceeded 20. 
 
2.6.3.1.5 Identification of cross-linked peptides 
Mass spectrometric raw files were analyzed via Thermo Xcalibur software and peptide 
peaks of interest were picked manually. A theoretical mass database of potential inter-
protein cross-links was built up using a spreadsheet by combining two peptides, which 
were identified in individual (non-cross-linked) enzymes but missed in the cross-linked 
enzyme complex by MASCOT database search. Additional peptide peaks only found in 
cross-linked spectra were screened against the mass database. Cross-link candidates were 
selected by the following rules: trypsin did not cut at the C-terminus of modified lysines 
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or lysines with proline on the C-terminus; up to two missed cleavages were allowed, but 
non-specific cuttings were not considered; peptide length was 5–30 amino acids; each 
cross-linked peptide had at least one lysine for cross-linking as well as a lysine or 
arginine at C-terminus; peaks showed up in at least duplicate experiments; mass error = 5 
ppm. Flexible modifications that might be obtained by oxidation or during SDS-PAGE 
running were applied to specific residues for identification and the respective mass 
variations were previously summarized.27 Identified cross-links were examined by 
Mascot automated target-decoy search against NCBI database to estimate false-discovery 
rate (FDR) and no protein hits were reported above identity threshold (p = 0.05) 
 
2.6.3.1.6 Hybrid protein docking 
Global docking and local docking were carried out to solve the structure of the mMDH-
CS-Aco complex. In global docking, an automated protein docking web server, Cluspro 
(http://cluspro.bu.edu/), was utilized.51-53 Cross-linked lysines identified by manual 
search were set as attracting residues. All proteins were treated as rigid bodies with their 
“open” conformations obtained from crystal structures, giving top 100-120 structures of 
highest score based on surface shape complementarity and free energies of desolvation 
and electrostatic interactions. The crystal structure of Aco, mMDH and CS were obtained 
from the Protein Data Bank (PDB: 1MLD, 1CTS and 7ACN). The 24 amino acid 
sequences at N-terminus are signal peptides, which are cut off from mature enzymes, so 
they were excluded from simulation. However, for the recombinant proteins, the FLAG-
tag and His-tag was included in model as well as in the final structures. Prior to local 
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docking, all model candidates were screened by Xwalk software suite to filter out false 
positives by distance constraints.54 Maximum Euclidean distance limit was set to 25 Å, 
resulting from a combination of DSG spacer arm length (7.7 Å), lysine side chain length 
(6 Å × 2) and backbone flexibility. In addition to Euclidean distance limit, solvent 
accessible surface (SAS) distance was set to 30 Å to mimic molecular flexibility of DSG. 
Solvent radius was 1.4 Å by default and set to 2 Å for SAS distance calculation. 
Rotamers were removed and only the distance of Cβ-Cβ between two lysines was 
calculated. A pair of lysines on two proteins in global candidates were considered as a 
potential cross-link, if their Xwalk-calculated separation is no more than the limits.55 
After distance filtering, global candidates bearing at least two potential cross-links were 
subject to local docking by another protein docking web server, Rosetta 
(http://rosie.rosettacommons.org/).56-58 Derived from each starting global structure, 10 
local candidates of lowest interface energy were screened again by Xwalk. Final complex 
structures were chosen based on two criteria: local candidates of lowest interface energy 
were clustered around a single position on the energy landscape and the structure had the 
highest number of potential cross-linkers in agreement with experimental results. 
Interfacial residues in final structures were determined when the measured Euclidean 
distance was less than 20 Å. 
 
2.6.3.1.7 Simulation of electrostatic surface potential 
Prior to simulation, docked structures were modified by PDB2PQR web server 
(http://nbcr-222.ucsd.edu/pdb2pqr_2.0.0/) to add missing hydrogens and/or heavy atoms 
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and to estimate their titration states.59, 60 Protein complexes were protonated with 
favorable hydrogen bonds. Charges and radius were assigned from Amber force field. 
PROPKA was used to predict pKa shifts in complexes at pH 7.4.61 Calculation of surface 
ESP by Poisson-Boltzmann equation was done by APBS web server 
(http://www.poissonboltzmann.org/docs/apbs-installation/)30, 62 with the following 
parameter settings: water molecules were not removed; no additional ions were added at 
zero ionic strength; biomolecular dielectric constant was set at 2; and solvent dielectric 
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Engineering New Hydrophobic Interfaces for 
Stimulus-Responsive Hydrogel Formation † 
 
3.1 Abstract 
We have rationally engineered a stimulus-responsive cross-linking domain based on a 
repeats-in-toxin (RTX) peptide to enable calcium-dependent formation of supramolecular 
hydrogel networks. The β-roll peptide isolated from the RTX domain is intrinsically 
disordered in the absence of calcium. In calcium rich environments, the peptide binds 
calcium ions and folds into a β-roll secondary structure composed to two parallel β-sheet 
faces. Previously, one face of the peptide was mutated to contain solvent exposed leucine 
side chains, which are localized only in the calcium-bound β-roll conformation. The 
ability of this mutant peptide to self-assemble into hydrogels was demonstrated in the 
presence of calcium with the aid of additional peptide-based cross-linking moieties. In 
this work, this approach is extended by engineering both β-roll faces to contain leucine 
residues, thereby doubling the cross-linking interface for each monomeric building block. 
These leucine rich surfaces impart a hydrophobic driving force for self-assembly. 
Extensive characterization was performed on this double-faced mutant to ensure the 
retention of calcium affinity and subsequent structural rearrangement similar to that of 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
†!A version of this chapter is published in Biomacromolecules (2014), 15: 3617-3624, with co-
authors Kevin Dooley and Scott Banta. B.B. cloned the genes, expressed and purified the 
proteins, analyzed the mutant peptides via circular dichroism, prepared hydrogels, performed 
microrheology experiments and assisted with the manuscript writing.!
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the wild-type domain. We genetically fused an α-helical leucine zipper capable of 
forming tetrameric coiled-coil bundles to the peptide and the resulting chimeric protein 
self-assembles into a hydrogel only in calcium rich environments. Since this new mutant 
peptide enables cross-linking on both surfaces simultaneously, a higher oligomerization 
state was achieved. To further investigate the cross-linking capability, we constructed 
concatemers of the β-roll with maltose binding protein (MBP), a monomeric globular 
protein, without the leucine zipper domains. These concatemers show a similar sol-gel 
transition in response to calcium. Several biophysical techniques were used to probe the 
structural and mechanical properties of the mutant β-roll domain and the resulting 
supramolecular networks. These results demonstrate that the engineered β-roll peptides 
can mediate calcium-dependent cross-linking for proteinaceous hydrogel formation 
without the need for any other cross-linking moieties. 
 
3.2 Introduction 
Protein-based biopolymer hydrogels composed of three-dimensionally cross-linked 
macroscopic networks have been widely investigated for a host of applications in the 
biomedical field because of their biocompatibility, predictable erosion rates, and tunable 
viscoelastic properties.1-5 Several excellent reviews are available that detail protein- and 
peptide-based self-assembly strategies.6-11 Biomolecules with the ability to respond 
“intelligently” to external stimuli such as pH, temperature, ionic strength, or light are 
often incorporated into monomeric polymer building blocks to trigger or disrupt self-
assembly through a variety of mechanisms.12-14 Calmodulin, elastin-like  polypeptides, 
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and α-helical leucine zipper domains have been used to actuate hydrogel formation in 
response to environmental cues, leading to successful implementation into microfluidic 
systems, biosensors, and vehicles for controlled release.1, 5, 15-20  
A rationally designed peptide based on the β-roll domain was previously reported 
that functions as a stimulus-responsive cross-linker for calcium dependent hydrogel 
formation.21 The β-roll scaffold is a modular, repeating polypeptide that undergoes a 
reversible structural rearrangement in response to calcium. The peptide is apparently 
intrinsically disordered in the absence of calcium and folds into a β-roll in calcium rich 
environments consisting of two parallel β-sheet faces separated by flexible turn regions 
(Fig. 3.1A).22, 23 Conserved aspartic acid residues in the turn regions are responsible for 
coordinating calcium ions. Only a C-terminal capping group is required for calcium-
induced folding of the polypeptides.24, 25  
Each β-sheet face in the folded conformation contains eight residues with solvent 
exposed side chains that project radially away from the hydrophobic core. In the previous 
study, one β-sheet face was mutated to contain leucine residues at these eight positions 
(Fig. 3.1B). The mutant leucine β-roll (Leuβ) was fused to a self-assembling α-helical 
leucine zipper domain (H) and a randomly coiled hydrophilic linker (S), which is 
included to provide flexibility and prevent aggregation. Both H and S domains have been 
extensively characterized previously.26-28 Without calcium, the helices form tetrameric 
coiled-coil bundles, but the β-roll domains remain unstructured, delocalizing the leucine 
rich patches and prohibiting HS-Leuβ supramolecular self-assembly. After calcium 
binding, the β-roll folds and the leucine rich faces are exposed creating a hydrophobic 
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driving force for oligomerization (Fig. 3.2A). The resulting calcium-responsive hydrogel 
networks have been characterized using a variety of techniques.21 
!
Figure 3.1 Homology models for WT and mutant β-roll domains with primary 
sequences. Homology models for WTβ (A), Leuβ (B), and DLeuβ (C) domains were 
generated with SWISS-MODEL (Swiss Institute of Bioinformatics) using a β-roll-
containing lipase as a template (PDB: 2Z8X). Side and top-down views are given for 
each construct in the folded conformation with the red spheres representing bound 
calcium ions. The side chains of the surface exposed residues are highlighted and 
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underlined in the primary sequences. The amino acids in magenta represent the wild-type 
residues, and the blue amino acids represent the rational leucine mutations. All images 
were rendered in PyMOL. 
In this study, we have expanded this approach by further engineering the Leuβ 
peptide to increase its cross-linking capacity. The folded β-roll domain consists of two β-
sheet faces, each with eight solvent exposed residues. We have now rationally engineered 
a “double-faced” leucine β-roll peptide (DLeuβ) such that all 16 positions are leucines 
(Fig. 3.1C). This should enable cross-linking on both sides of the folded construct 
simultaneously, thereby increasing the potential oligomerization state and cross-linking 
density (Fig. 3.2B). Previously, Leuβ domains were approximated to have an association 
number of 2 (Fig. 3.2A), which required significant protein concentrations (60 mg/mL) 
and additional cross-linking moieties to assemble into supramolecular networks. We 
hypothesize that DLeuβ will self-assemble at lower weight percentages as concentration 
dependent sol-gel transition and oligomerization state of the cross-linking domain are 
directly related.28 Further, DLeuβ should be able to induce calcium-dependent self-
assembly without the additional cross-linking provided by the α-helical leucine zippers. 
Circular dichroism (CD), fluorescence resonance energy transfer (FRET), and bis-ANS 
binding were used to ensure DLeuβ folds in a similar manner as the wild-type β-roll 
(WTβ) and Leuβ in response to calcium. The mechanical properties of HS-DLeuβ were 
analyzed using a microrheology technique and compared to results obtained previously 
for HS-WTβ and HS-Leuβ.21 Finally, the utility of the DLeuβ as a stand-alone cross-
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linking domain was assessed by creating fusions to maltose binding protein (MBP) and 
analyzing the resulting hydrogel networks (Fig. 3.2C). 
!
Figure 3.2 Monomeric building blocks and assembled hydrogel networks. All 
cartoons represent β-roll domains in the folded conformation after calcium (red) binding. 
(A) HS-Leuβ monomer composed of an α-helical leucine zipper (yellow), a randomly 
coiled linker (purple), and the mutant Leuβ (light blue). The assembled network depicts 
an association number of 2 for Leuβ. (B) HS-DLeuβ monomer composed of an α-helix, 
linker, and DLeuβ mutant (green). Association numbers of > 2 are depicted. (C) MBP-
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DLeuβ-MBP-DLeuβ monomer. The DLeuβ can achieve higher oligomerization states 
and does not require cross-linking provided by the helical bundles. MBP is a monomeric 
protein and does not naturally self-assemble. α-Helices and MBP were rendered in 
PyMOL using PDB files 1GCL and 1YTV, respectively. 
 
3.3 Materials and Methods 
3.3.1 Materials  
Amylose resin, the MBP expression kit, and all enzymes for DNA cloning were 
purchased from New England Biolabs. Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
and ampicillin sodium salt were purchased from Gold Biotechnology. Amicon centrifugal 
filters were purchased from Millipore. All materials for polyacrylamide gel 
electrophoresis (PAGE) experiments as well as 1 µm Nile Red FluoSpheres for particle 
tracking were purchased from Life Technologies. All oligonucleotides were purchased 
from Integrated DNA Technologies. BL21 Escherichia coli cells were purchased from 
Bioline. All other reagents were purchased from Sigma-Aldrich unless otherwise stated. 
 
3.3.2 Cloning into the pMAL Expression Plasmid 
Cloning and expression of the WTβ and Leuβ constructs have been described 
previously.21 The DLeuβ peptide was assembled by annealing and extending two 
overlapping oligonucleotides encoding for the entire gene. The C-terminal cap of the β-
roll domain was amplified from the pDLE-9-cyaA plasmid, a gift from Dr. Daniel Ladant 
(Institute Pasteur), and appended to the DLeuβ gene by overlap extension PCR.22 KpnI 
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and HindIII restriction sites were added for ligation into a modified pMAL plasmid 
containing a self-cleaving intein, a gift from Dr. David Wood (Ohio State University).29 
DLeuβ was also cloned into the same pMAL-Intein backbone modified with an α-helical 
domain (H) and a soluble linker (S) from the pQE9AC10Acys plasmid, a gift from Dr. 
David Tirrell (California Institute of Technology).26 The resultant constructs, pMAL-
Intein-DLeuβ and pMAL-Intein-HS-DLeuβ, were transformed into BL21 E. coli cells for 
expression. 
Concatemers of MBP and DLeuβ (Fig. 3.2C) were cloned into the pMAL-c4e 
vector backbone. DLeuβ with the C-terminal cap was amplified out of the pMAL-Intein-
DLeuβ construct and cloned using EcoRI and BamHI restriction sites. MBP was 
amplified from the pMAL-c4e construct and inserted after DLeuβ-Cap via BamHI and 
SalI restriction sites. Lastly, the second DLeuβ-Cap was amplified and cloned using SalI 
and HindIII restriction sites, resulting in the final construct: pMAL-MBP-DLeuβ-MBP-
DLeuβ. During this cloning process, we also created the construct pMAL-MBP-DLeuβ to 
be used as a negative control. All oligonucleotide sequences for cloning experiments as 
well as primary sequences for all proteins can be found in the Supplementary Information 
(Tables S3.1 and S3.2). 
 
3.3.3 Expression and Purification of DLeuβ Constructs  
All DLeuβ constructs were expressed identically in Terrific Broth (TB) supplemented 
with 100 µg/mL ampicillin and 2 g/L D-glucose. Saturated 10 mL overnight cultures 
containing the appropriate transformed cells were diluted in 1 L of sterilized TB and 
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grown at 37 °C and shaken at 220 rpm. Once the optical density (OD) at 600 nm reached 
0.6, protein expression was induced with IPTG to a final concentration of 0.3 mM. 
Expression was carried out for either 5 h at 37 °C or 16 h at 25 °C, after which cells were 
harvested via centrifugation at 5000 x g for 10 min. Cell pellets were resuspended in 50 
mL of MBP column buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, pH 7.4) per 
liter of culture. Expressed protein was liberated from the cells by microtip sonication for 
6 min on ice (Sonicator 3000, QSonica). Cell debris and insoluble protein were collected 
via centrifugation at 15000 x g for 30 min and discarded. Soluble protein was diluted 5-
fold in MBP column buffer and loaded onto equilibrated amylose resin drip columns. The 
columns were washed to remove any nonspecifically bound protein. MBP-DLeuβ and the 
concatemers were eluted with maltose and further purified on a Superdex HiLoad 16/60 
size exclusion chromatography column (GE Healthcare). Columns containing proteins 
with the intein domain were saturated with intein cleaving buffer (137 mM NaCl, 2.7 mM 
KCl, 8.1 mM Na2HPO4, 1.76 mM KH2PO4, 40 mM bis-Tris, 2 mM EDTA, pH 6.2), 
capped, and incubated at 37 °C for 12−16 h. Cleaved fusion proteins were eluted with 50 
mL of MBP column buffer and concentrated using either 10 or 30 kDa molecular weight 
cut off (MWCO) centrifugal filter devices. The samples were buffer exchanged into 20 
mM bis-Tris, 25 mM NaCl, pH 6.0 and loaded onto a 16/10 Q FF ion exchange column 
(GE Healthcare). Target proteins were eluted using a linear NaCl gradient from 25 to 500 
mM NaCl over 20 column volumes. Protein concentration was determined by absorbance 
at 280 nm using calculated extinction coefficients available in the Supplementary 
Information (Table S3.3). Purified protein fractions were pooled and concentrated, and 
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buffer exchanged into the appropriate assay buffer. Purity and molecular weight for HS 
hydrogel forming constructs were confirmed by SDS-PAGE and MALDI-MS. These 
results are provided in the Supplementary Information (Fig. S3.1 and Table S3.4). 
 
3.3.4 Circular Dichroism Spectroscopy  
β-Roll samples (100 µM) were loaded into a 0.1 mm path length quartz cuvette and 
analyzed on a J-815 CD spectrometer (Jasco). The temperature was held constant at 25 
°C via a Peltier junction temperature controller. Samples were incubated in the presence 
or absence of CaCl2 prior to analysis. All experiments were performed in triplicate in 50 
mM Tris pH 7.4. Titration data were fit to the Hill equation using SigmaPlot nonlinear 
regression software. 
 
3.3.5 Bis-ANS Dye Binding  
β-Roll samples (1 µM) were prepared in 50 mM Tris pH 7.4 in the presence and absence 
of 50 mM CaCl2 prior to the addition of 5 µg/mL bis-ANS dye. Samples were loaded into 
a 1 cm path length UV cuvette and analyzed on a SpectraMax M2 cuvette reader 
(Molecular Devices). Fluorescence emission was monitored from 420 to 600 nm 







3.3.6 Fluorescence Resonance Energy Transfer  
β-roll samples (1 µM) were prepared in 20 mM PIPES pH 6.8 supplemented with 120 
mM NaCl and 10 mM KCl. A terbium (III) chloride stock solution was prepared in the 
same buffer. β-Roll samples were titrated with increasing amounts of terbium in 96-well 
microtiter plates and incubated at 25 °C for 30 min prior to analysis. Tyrosine residues in 
the β-roll domain were excited at 282 nm, and the fluorescence emission from bound 
terbium ions was monitored at 545 nm. All data were collected in triplicate. 
 
3.3.7 Hydrogel Preparation  
All β-roll samples were prepared in a similar manner. Volumes of 500 µL of diluted 
protein samples were lyophilized in 5 mM Tris pH 7.4 supplemented with CaCl2 or 
MgCl2. Self-assembly was initiated by reconstituting the lyophilized protein in 1/10 the 
original volume, resulting in 4−6 wt % protein in 50 mM Tris pH 7.4. Mechanical 
mixing, vortexing, and centrifugation were used to ensure all of the lyophilized protein 
was rehydrated. Samples were allowed to set at room temperature for 30 min prior to 
analysis. 
 
3.3.8 Microrheology  
Passive microrheology experiments were performed as previously described with minor 
modifications.21 When rehydrating lyophilized protein for particle tracking experiments, 
deionized pure water was supplemented with 1 µm FluoSpheres conjugated with Nile 
Red. The samples were mixed, loaded onto a glass slide, and sealed with a coverslip. 
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Particle motion was tracked using an Olympus IX81 motorized inverted microscope with 
a 40 × objective. A high-speed Hamamatsu C9300 digital camera was used to record 
individual particle trajectories at an exposure time of 33 ms. For each run, 300 frames of 
video were recorded at 30 frames per second. Three runs were recorded per sample to 
ensure a good statistical average. All runs were recorded on a ThorLabs air table to 
eliminate ambient vibrational noise. All videos were analyzed using MetaMorph software 
and converted to TIFF stacks in ImageJ.30 Particle tracking and rheological analysis were 
completed in Interactive Data Language (IDL) software using algorithms created by 
Crocker et al.31-34 Mean square displacement (MSD) plots were generated and used to 
compare the mechanical properties of the prepared samples. 
 
3.4 Results 
3.4.1 DLeuβ Characterization 
The rationally designed “double-faced” leucine β-roll was expressed, purified, and 
characterized by CD, bis-ANS dye binding, and terbium binding assays to evaluate its 
response to calcium and self-assembly capability. Previously, WTβ and Leuβ were 
characterized using these same techniques.21 Samples (100 µM) of purified protein were 
analyzed by CD in the presence and absence of 10 mM CaCl2. The resulting spectra are 
shown in Figures 3.3A-C for WTβ, Leuβ, and DLeuβ constructs, respectively. All three 
proteins demonstrated similar conformational changes in response to calcium. In 
calcium-free environments, the spectra exhibited large negative peaks at 198 nm, which 
is indicative of randomly coiled peptide. Significant changes in secondary structure were 
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observed in 10 mM CaCl2 for all β-roll domains. A random coil to β-sheet transition was 
evidenced by the emergence of a negative peak at 218 nm and is consistent with previous 
reports.24 Slight variations in the CD spectra were most likely caused by small amounts 
of contamination in the samples from the recombination expression process. A titration 
was performed by monitoring the CD signal at 218 nm over a range of CaCl2 
concentrations to elucidate the calcium binding parameters for each peptide (Fig. 3.3D). 
The data were fit to the Hill equation, and the resulting parameters are summarized in 
Table 3.1. Leuβ and DLeuβ bound calcium with affinities similar to that of the wild-type 
peptide, and all constructs exhibited cooperative binding with Hill coefficients (N) >1. 
Full CD spectra for all three constructs at all calcium concentrations tested are available 




Figure 3.3 Circular dichroism characterization. Mean residue ellipticity (MRE) 
plotted over a range of wavelengths for WTβ (A), Leuβ (B), and DLeuβ (C) in the 
presence (• • •) and absence (−) of 10 mM CaCl2. (D) Relative MRE at 218 nm for WTβ (
), Leuβ (), and DLeuβ () plotted over a range of calcium concentrations. All data 
were collected in triplicate in 50 mM Tris pH 7.4. Titration data were fit to the Hill 
equation using nonlinear regression software. The calcium binding parameters are 





Table 3.1 Calcium binding properties of WTβ, Leuβ and DLeuβ peptides 
Construct Kd (mM) N R2 
WT 0.91 ± 0.02 2.3 ± 0.1 0.997 
Leu 0.82 ± 0.01 3.1 ± 0.1 0.998 
DLeu 1.18 ± 0.02 4.6 ± 0.3 0.998 
 
Bis-ANS is a commonly used molecular probe that binds to protein surfaces 
through hydrophobic interactions causing an increase in fluorescence.35 It can be used to 
detect changes in protein structure and has been previously used to examine the structural 
transition of β-roll peptides in response to calcium binding.21, 24 Purified DLeuβ was 
incubated with bis-ANS in the presence and absence of calcium, and the resulting 
emission spectra are given in Figure S3.2B. Significant increases in fluorescence were 
observed in the calcium rich samples, indicating a disordered to folded transition. 
Terbium, a fluorescent calcium analogue, was shown previously to trigger β-roll 
folding.21, 24 In the folded conformation, bound terbium ions are in close proximity to a 
tyrosine residue in the seventh repeat of the β-roll. Excitation of the tyrosine residue 
results in a fluorescence emission from the terbium ion proportional to the distance 
between the two.36 A terbium titration was performed while monitoring this fluorescence 
emission and the resulting plot is shown in Figure S3.2A. While this does not directly 
report calcium-induced folding, it is consistent with the CD and bis-ANS data suggesting 




3.4.2 HS-DLeuβ Microrheology  
An α-helical leucine zipper domain (H) and an unstructured hydrophilic linker (S) were 
appended to the N-terminus of the DLeuβ (Fig. 3.2B). It was previously demonstrated 
that this N-terminal fusion does not interfere with β-roll folding in response to calcium.21 
Self-assembly into noncovalently cross-linked supramolecular networks was analyzed by 
passive microrheology. Time averaged MSDs of 1 µm fluorescent particles embedded 
into the samples were calculated over a range of lag times. The dynamics of the 
embedded particles report the mechanical properties of the surrounding 
microenvironment. In a purely viscous fluid, the tracer particles are allowed to freely 
diffuse and the MSD scales linearly with the lag time (τ). In an elastic medium, the MSD 
becomes independent of lag time and is characterized by a pronounced plateau over a 
sampled time domain.32, 33, 37 Initial experiments were conducted at 6 wt %, the 
concentration at which HS-Leuβ self-assembles in calcium rich environments. It should 
also be noted that 6 wt % HS-WTβ remained viscous regardless of the calcium 
concentration in a previous study.21 The results from the 6 wt % experiments are 
provided in Figure 3.4. HS-DLeuβ remained viscous in 50 mM MgCl2 at 6 wt % and 
assembled into an elastic network in the presence of 50 mM CaCl2 over the explored time 
domain (Fig. 3.4A). An image of the assembled hydrogel is provided in Figure 3.4E. 
The rheology experiments were repeated at lower weight percentages to explore 
the lower critical protein concentration required for HS-DLeuβ self-assembly. The results 
at 4 wt % are shown in Figures 3.4B-D. Again, the HS-WTβ construct remained viscous 
in both magnesium and calcium rich solutions (Fig. 3.4C). HS-Leuβ appeared largely 
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viscous in both magnesium and calcium as well (Fig. 3.4D). HS-DLeuβ remained viscous 
in magnesium and self-assembled into an elastic network over the sampled time domain 
in the presence of calcium (Fig. 3.4B), similar to that observed at 6 wt %. 
To further explore the utility of the DLeuβ peptide and to take full advantage of 
the dynamic conformational response of the β-roll domain, we characterized the 
mechanical properties of 6 wt % HS-DLeuβ at varying calcium concentrations. Since 
self-assembly is mediated by β-roll folding, viscoelastic intermediate materials should be 
generated by using calcium concentrations in the dynamic range of β-roll folding. Figure 
3.5 demonstrates the transition of 6 wt % HS-DLeuβ from largely viscous at low calcium 
concentrations to largely elastic at 10 mM calcium in the time range sampled. 






Figure 3.4 Time averaged MSD measurements for HS-β-roll constructs. 6 wt % (60 
mg/mL) HS-DLeuβ MSD measurements in the presence of 50 mM magnesium () and 
50 mM calcium () are given in panel (A). Identical experiments were performed at 4 wt 
% (40 mg/mL) for HS-DLeuβ (B), HS-WTβ (C), and HS-Leuβ (D). Only the HS-DLeuβ 
construct underwent a sol-gel transition in response to calcium at 4 wt %. Panel (E) 




Figure 3.5 Time averaged MSD measurements at various calcium concentrations for 
HS-DLeuβ. 6 wt % (60 mg/mL) HS-DLeuβ samples were prepared in increasing CaCl2 
concentrations. MSD measurements in 0 mM (), 0.5 mM (), 1.0 mM (), 3.0 mM    
(), 5.0 mM (), and 10 mM () calcium are given. A transition from linear increases 
in MSD with respect to lag time in low calcium concentrations to a more pronounced 
plateau at higher calcium concentrations was observed. 
 
3.4.3 MBP-DLeuβ Concatemer Microrheology  
In order to assess the utility of DLeuβ as a stand-alone cross-linking domain, we 
genetically constructed concatemers of DLeuβ and MBP. The monomeric block is shown 
in Figure 3.2C. In this case, the linkers are either composed of a poly asparagine linker at 
the C-terminus of MBP or the unstructured capping group at the C-terminus of DLeuβ. 
Primary sequences for all domains used in this work are provided in Table S3.1. 
Significantly higher weight percentages were required (21.3 wt %) to maintain the same 
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molar concentration of cross-linking content used in the 6 wt % HS-β-roll experiments. 
Rheological analysis was performed as described above and the results are provided in 
Figure 3.6A. A clear sol-gel transition was observed in the presence of calcium, 
demonstrated by the lag time independence of the MSD, when compared to the 
magnesium control. A photograph of the cross-linked hydrogel suspended on a glass 
coverslip is provided in Figure 3.6C. Rheological analyses were also performed on 
samples with identical molar cross-linking content as the 4 wt % HS-β-roll experiments 
(14.2 wt %), and similar results were obtained. The MSD of samples prepared in the 
absence of calcium remained largely linear with respect to lag time while samples 
prepared in 50 mM calcium self-assembled into hydrogel networks in the time scales 
explored (Fig. 3.6B). 
To supplement this data, the rheological properties of a truncated monomeric unit 
containing only one cross-linking domain (MBP-DLeuβ) were tested in the presence and 
absence of calcium at 21.3 and 14.2 wt %. As expected, these samples remained visually 
viscous, regardless of protein or calcium concentration, which is consistent with the MSD 




Figure 3.6 Time averaged MSD measurements for DLeuβ-MBP concatemers. Panel 
(A) provides MSD measurements for 21.3 wt % DLeuβ-MPB concatemers in the 
presence of 50 mM magnesium () and 50 mM calcium (). The increased weight 
percentage was necessary to normalize the molar cross-linking content to the 6 wt % 
samples described previously. Panel (B) shows an identical experiment performed at 14.2 
wt %, normalized to the molar cross-linking content of the 4 wt % samples described in 
Figure 3.4. Panel (C) shows an image of 21.3 wt % DLeuβ-MBP concatemer in the 







In this work, we have rationally engineered a stimulus responsive cross-linking peptide 
by exploiting the calcium induced conformational change intrinsic to the β-roll domain. 
The Leuβ and DLeuβ peptides require low millimolar concentrations of calcium to 
trigger self-assembly, which affords tight control over the gelation process. Additionally, 
viscoelastic properties can be allosterically regulated by simply adjusting the calcium 
concentration. Several biophysical techniques were used to investigate the structural 
responses of the mutant peptides to calcium, the lower critical protein concentration 
required for self-assembly, and the mechanical properties of the resulting supramolecular 
networks. 
It was previously shown that mutating one face of the β-roll peptide (Leuβ) has 
minimal impact on the affinity for calcium or the structural rearrangement induced upon 
calcium binding.21 By mutating both faces to contain leucine residues (DLeuβ), we have 
substantially increased the solvent exposed hydrophobic surface area of the folded 
construct. Despite the significant increase in hydrophobicity, no observable effects on 
protein solubility were detected for DLeuβ when compared to the other two constructs. 
Similar CD spectra were obtained in the presence and absence of 10 mM calcium for all 
three β-roll peptides indicating a disordered to β-sheet transition (Fig. 3.3A-C). CD 
titration data were fit to the Hill equation, which assumes a two state binding model 
(disordered and folded) and multiple calcium binding sites. Fits from the titration data 
yielded similar affinities for calcium (∼1 mM); however, larger variations in the Hill 
coefficients, a measure of ligand binding cooperativity, were observed. Interestingly, both 
102!
!
mutants bind calcium with a higher cooperativity than WTβ (Table 3.1); however, the 
relationship between solvent exposed hydrophobicity and Hill coefficient is not entirely 
clear. The data suggested that higher calcium concentrations were required to initiate 
folding, especially for the double mutant. The increased hydrophobicity of the DLeuβ 
may nonspecifically stabilize the peptide in the disordered conformation. 
Bis-ANS dye binding experiments were used to supplement the CD data and 
ensure the DLeuβ mutant retained the calcium binding properties intrinsic to the WTβ 
domain. Significant increases in fluorescence emission were detected in calcium rich 
solutions as compared to the spectra obtained in the absence of calcium (Fig. S3.2B). 
This increase in fluorescence can be attributed to an increase in hydrophobic surface area 
amenable to dye binding caused by calcium-induced folding. These results are in 
agreement with previously reported data for WTβ and Leuβ.21, 24 Terbium binding assays 
were also conducted to further ensure the performance of the DLeuβ mutant (Fig. S3.2A). 
Increases in fluorescence emission were observed with increasing terbium concentration, 
plateauing around 200 µM. Near identical hyperbolic responses were observed for WTβ 
and Leuβ. However, it is important to note that while terbium acts as a calcium analogue, 
it does not directly report calcium affinity. Taken together, the CD, bis-ANS, and terbium 
binding data suggest that all three constructs bind calcium in a similar manner resulting in 
a transition from a disordered state to a spatially organized β-roll structure. 
After the preliminary characterization was completed, the self-assembly 
capabilities of DLeuβ were assessed by two separate approaches. First the previous study 
was expanded by appending an α-helical leucine zipper domain (H) and a soluble linker 
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(S) to the N-terminus of DLeuβ (Fig. 3.2B). Microrheology experiments performed at 6 
wt % confirmed HS-DLeuβ self-assembly into an elastic network in 50 mM CaCl2 while 
remaining a viscous liquid in 50 mM MgCl2 in the time domain explored (Fig. 3.4A). 
These experiments verified what was previously observed with Leuβ. In the absence of 
calcium, the data are consistent with a viscous solution, meaning the tracer particles can 
freely diffuse through the medium and ⟨r2(τ)⟩ increases linearly with τ. The helical 
domains can assemble into tetrameric coiled-coil bundles, but the unstructured β-roll 
domains prohibit the formation of an elastic network. In response to increasing calcium 
concentrations, the designed β-roll domains begin to fold, thus providing a driving force 
for self-assembly. The viscosity of the medium increases causing a markedly slower 
growth rate of MSD vs τ and a pronounced plateau in the observable time range. In 50 
mM CaCl2, we expect the β-roll domains to be fully folded thus localizing the leucine 
side chains into a structurally well-defined surface suitable for cross-linking. 
In previous work, the Leuβ peptide contained leucine residues on only one face of 
the folded β-helix which yielded a potential association number of 2 (Fig. 3.2A).21 This 
required protein concentrations of 60 mg/mL (6 wt %) to induce self- assembly. At lower 
concentrations, there were not enough cross-links to sustain an elastic network. We 
hypothesized that by designing a β-roll peptide with cross-linking interfaces on both sides 
of the folded construct, the oligomerization state could potentially be increased (Fig. 
3.2B). Association numbers higher than 2 should facilitate self-assembly at lower protein 
concentrations. To investigate this, we prepared 40 mg/mL (4 wt %) samples of HS-
WTβ, HS-Leuβ, and HS-DLeuβ. Self-assembly was observed only for the HS-DLeuβ 
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sample in calcium. All constructs remained viscous in the magnesium controls (Fig. 3.4). 
HS-WTβ and HS-Leuβ MSD plots were indicative of a viscous medium in the presence 
of calcium as well. These rheological experiments suggest that DLeuβ has a higher 
association number than the Leuβ construct. At protein concentrations below 4 wt %, HS-
DLeuβ assembled into several small elastic aggregates, but they did not constitute the 
entire volume, indicating fluctuations in local protein concentration. 
We next investigated the potential of the DLeuβ cross-linking domain to 
allosterically regulate the mechanical properties of a 6 wt % gel. Samples were incubated 
in increasing concentrations of calcium, and the resultant MSD plots are provided in 
Figure 3.5. A clear transition was observed from a characteristically viscous medium at 
low calcium to an elastic medium at 10 mM calcium over the time domain sampled. The 
5 mM calcium sample displayed characteristics of each limiting rheological behavior, 
that is, linear MSD growth with τ and limited fluctuation of MSD amplitude, particularly 
at small lag times. This is indicative of a viscoelastic intermediate in the given time 
scales.37 This phenomena was previously observed with the HS-Leuβ construct, however, 
the transition from a viscous medium to a hydrogel occurred over a broader range of 
calcium concentrations.21 A strong correlation can be drawn between the calcium binding 
parameters of the two mutants and the allosteric regulation of the mechanical properties. 
The Leuβ peptide binds calcium cooperatively with a Hill coefficient of 3.1 as compared 
to 4.6 for DLeuβ. This means DLeuβ undergoes the structural transition from unfolded to 
folded over a more narrow range of calcium concentrations (Fig. 3.3D), which is 
reflected in the sharp change in mechanical properties in Figure 3.5. The structural 
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transition of Leuβ occurs over a broader range of calcium concentrations giving rise to a 
broader range of viscoelastic intermediates. These results further confirm our hypothesis 
that self-assembly is driven by β-roll folding. 
To further test the utility of the DLeuβ as a stimulus responsive cross-linking 
domain, we constructed concatemers of DLeuβ and MBP (Fig. 3.2C), eliminating the α-
helical leucine zipper domains. The microrheology results indicate similar calcium 
dependent self-assembly properties as seen with the HS constructs (Fig. 3.6). Both 21.3 
and 14.2 wt % samples in magnesium had significantly more viscoelastic character than 
the corresponding HS samples (Fig. 3.6A, B). In order to normalize the molar cross-
linking content between the HS and concatemer experiments, significantly higher protein 
concentrations were required due to the large size of MBP. However, a clear transition in 
mechanical properties was still observed for the concatemer samples at both weight 
percentages tested (Fig. 3.6A, B). These results demonstrated that the DLeuβ mutant has 
the ability to create enough elastically effective associations to actuate self-assembly in 
the presence of calcium, without depending on additional cross-linking provided by the 
leucine zipper domains. A lower critical protein concentration for self-assembly was 
determined to be approximately 14 wt % (adjusted for molar cross-linking content), 
which is in agreement with the HS experiments discussed above. 
The DLeuβ peptide is considerably different from other stimulus-responsive 
protein-associating domains used for hydrogel cross-linking. β-roll domains do not 
naturally participate in self-assembly or biomolecular recognition; the self-assembly 
capabilities were rationally designed and engineered into the stimulus-responsive scaffold 
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itself. More commonly, a naturally associating domain is placed in an environment, 
which destabilizes the cross-linking interactions such as higher pH, temperature or by 
addition of denaturation agents. In contrast, the DLeuβ can be easily modulated from 
disordered to structured and, in turn, viscous to elastic by simply adjusting the calcium 
concentration. This may also offer a convenient strategy to encapsulate protein domains 
or cells inside a β-roll cross-linked hydrogel. Encapsulation targets can be incubated with 
soluble β-roll cross-linking domains after which calcium can be added to trigger 
macromolecular assembly, trapping protein or cells inside. Catalytically active proteins 
can also be genetically inserted in between β-roll cross-linking domains to create 















3.6 Supplementary Information 
3.6.1 Supplementary Figures 
!
Figure S3.1 SDS-PAGE analysis of hydrogel forming constructs. Purified HS-WTβ, 
HS-Leuβ, and HS-DLeuβ are given in lanes (a)-(c), respectively. It was previously shown 
that the alpha helical leucine zippers run artificially large on SDS PAGE gels.38 Also, 
peptide hydrophobicity has been linked to gel shifting which most likely accounts for 
differences in apparent molecular weights for these three constructs.39 Theoretical 
molecular weights and MALDI-MS results are given in Table S3.4. Lane (d) shows the 




Figure S3.2 DLeuβ preliminary characterization. 1 µM DLeuβ samples were 
incubated with increasing terbium concentrations in panel (A). An increase in relative 
fluorescence is indicative of terbium binding and β-roll folding. This hyperbolic response 
is similar to previously characterized RTX domains using this terbium binding assay. The 
results of the bis-ANS binding experiment are given in panel (B). In the absence of 
calcium (), the peptide is largely disordered and does not contain suitable hydrophobic 
patches for bis-ASN dye binding. In 50 mM CaCl2 (⋅ ⋅ ⋅), the mutant peptide folds and 









Figure S3.3 Raw circular dichroism spectra for all RTX peptides. 100 µM β-roll 
samples were used to generate full CD spectra for the WTβ, Leuβ, and DLeuβ peptides, 
given in panel (A)-(C) respectively. The legends on the right of each panel indicate the 
millimolar calcium concentration for each spectrum. All three peptides indicate a 
disordered-to-folded structural rearrangement in response to increasing calcium 




Figure S3.4 Time averaged MSD calculations for MBP-DLeuβ fusion protein. (in the 
presence of magnesium (○) and calcium (●)) Panel (A) shows the results from the 21.3 
wt % MBP DLeuβ negative control construct. In magnesium, the sample appears viscous 
in the observable frequency range. In 50 mM CaCl2, the MSD begins to flatten out, 
indicating an increase in viscosity. However, the MSD is not completely independent of 
lag time, as was observed with the concatemers given in Figure 3.6. Similar results are 
given in panel (B) for 14.2 wt % samples. Hydrogel assembly was not observed for these 









3.6.2 Supplementary Tables 
Table S3.1 Protein primary sequences 



















































































Table S3.2 PCR primers for cloning experiments 
Cloning 

















Forward 5’ ATCAACGCAGGCGCTGACCAG 3’ 




































Table S3.3 Protein properties. All theoretical molecular weights and extinction 








WTβ 15.92 17,780 
Leuβ 15.87 16,500 
DLeuβ 15.96 16,500 
HS-WTβ 31.92 24,750 
HS-Leuβ 31.87 23,470 
HS-DLeuβ 31.97 23,470 
MBP-DLeuβ-MBP-DLeuβ 115.7 162,440 
 
 
Table S3.4 MALDI-MS results for HS-containing constructs. Theoretical molecular 
weights for all HS constructs were calculated using the ExPASy ProtParam tool and 
compared to those obtained by MALDI. 
Construct Theoretical MW (kDa) 
MALDI MW 
(kDa) Error (%) 
HS-WTβ 31.92 32.65 2.27 
HS-Leuβ 31.87 32.06 0.61 
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Catch & Release of Target Molecules: On/Off 
Biomolecular Recognition via Stimulus-
Responsive β-roll Domain † 
!
4.1 Abstract 
Alternative scaffolds for biomolecular recognition are being developed to overcome some 
of the limitations associated with immunoglobulin domains. The RTX domain is a repeat 
protein sequence that reversibly adopts the β-roll secondary structure motif specifically 
upon addition of calcium. Using ribosome display, an RTX peptide library was selected 
to identify lysozyme binders in the presence of calcium and several mutants were 
identified with low micromolar dissociation constants. After concatenation of the 
mutants, a 500-fold increase in the overall affinity for lysozyme was achieved leading to 
a peptide with an apparent dissociation constant of 65 nM. The peptide was immobilized 
for affinity chromatography, whereby it was shown that the concatenated β-roll mutant 
reversibly captures the target in the presence of calcium and releases it upon removal of 
calcium ions. The development of allosterically regulated structural scaffolds could be 
used to control biomolecular recognition in a variety of biotechnology applications. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
† A version of this chapter is under review, with co-authors Kevin Dooley, Géza Szilvay, Mark 
Blenner and Scott Banta. B.B. constructed and characterized all mutants, performed isothermal 





Evolved biomolecular recognition is central for the continuity of life. Most regulatory and 
signaling events within and between cells depend on transient interactions between 
biomolecules. Antibodies have been the focus of the majority of biotechnology research 
involving biomolecular recognition and a great deal of effort has been focused on these 
immunoglobulin domains as engineered molecular recognition scaffolds.1-3 The 
tremendous potential of the engineered biomolecular recognition approach is continuing 
to emerge with the use of monoclonal antibodies as cancer therapeutics.4 A key feature in 
the engineering of biomolecular recognition for therapeutic applications is structural 
stability, which is required for formulation, storage, and prevention of unwanted 
aggregation.5-7  
 However not all biomolecular recognition applications (diagnostics, protein 
purification etc.) require the same level of structural stability. In nature, there is a 
growing number of examples of proteins and peptides exhibiting conformationally-
dynamic behavior, which allows them to expand their biomolecular recognition 
capabilities.8 This is exemplified by intrinsically disordered proteins, which have high-
specificity and low-affinity interactions with multiple ligands.9, 10 For example, the C-
terminal tail of the transcription factor p53 adopts different structures upon interaction 
with different partners, such that its dynamic conformation leads to multiple modes of 
binding.9, 11 Over the last few decades, alternative non-immunoglobulin domains have 
been proposed as highly stable scaffolds for use in biomolecular recognition 
applications.5, 12, 13 Affibodies, designed ankyrin repeat proteins (DARPins) and leucine 
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rich repeats (LRRs) are among these alternative domains.14-17 However, the use of 
conformationally dynamic or intrinsically disordered motifs in engineered biomolecular 
recognition has been largely unexplored. 
 The β-roll secondary structure motif is a flattened corkscrew-like structure with β-
strands separated by calcium binding turns that form two β-sheet faces (Fig. 4.1)18-20 The 
most studied β-roll domain comes from the Block V repeat-in-toxin (RTX) domain21 of 
adenylate cyclase from Bordetella pertussis. This peptide domain is thought to enable 
secretion of the protein through the type 1 secretion system.22, 23 It remains unfolded in 
the low intracellular calcium concentrations (<0.1 mM) and when the adenylate cyclase 
protein is secreted C-terminus first, the RTX domain undergoes a polarized 
conformational change upon exposure to high extracellular calcium concentrations.18, 24-26 
Thus the β-roll structure serves as a calcium dependent switch to ensure the functional 
folding of the catalytic domain of the enzyme.19, 27 The folding of the isolated Block V 
peptide is reversible, calcium specific, requires C-terminal capping and is entropically 
stabilized.26-30 Its native state with its polarized folding mechanism makes it a unique 
scaffold for exploring conditionally dependent biomolecular recognition. The recently 
discovered crystal structure of this domain has further elucidated its folding mechanism.25 
 This RTX domain exhibits allosteric regulation but it is not known to participate 
in biomolecular recognition. We hypothesized that amino acids on the β-sheet face of the 
folded β-roll domain could be engineered to create a binding interface, specifically 
controlled by the presence of calcium. A library of RTX mutants was created and several 
rounds of ribosome display were performed to select RTX mutants that conditionally 
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bind hen egg white lysozyme, which has been a model target in directed evolution 
research.31-33 By selecting peptides that bind the lysozyme target, we have begun to 
explore the idea of controllable self-assembly and conformationally-dependent ligand 
capture. The reversibility of calcium binding allows the engineered molecular recognition 
to be controllable and thus, calcium-triggered target “catch and release” can be achieved. 
 
4.3 Materials and Methods 
4.3.1 Plasmids and Chemicals 
Block V RTX domain and the capping group were amplified out of pDLE9-CyaA, a gift 
from Dr. Daniel Ladant (Institute Pasteur, Paris), as described before.34 The intein 
domain from pET-EI/OPH35 was a gift from Dr. David Wood (Ohio State University, 
Columbus). The ribosome display vector (pRDV, GenBank AY327136.1) was a gift from 
Dr. Andreas Plückthun (University of Zurich, Zurich).36 Restriction enzymes for cloning 
experiments, amylose resin and the PURExpress protein synthesis kit were purchased 
from New England Biolabs. Pre-blocked streptavidin coated plates, the RETROscript 
reverse transcription kit, Terrific Broth media for protein expression and FITC-labeled 
lysozyme were purchased from Thermo Fisher Scientific. The RNeasy mini kit was 
purchased from QIAGEN. Isopropyl β-D-1-thiogalactopyranoside (IPTG) and ampicillin 
sodium salt, were purchased from Gold Biotechnology. Amicon centrifugal filters were 
purchased from Millipore. Sodium dodecyl sulfate polyacrylamide electrophoresis gels 
(SDS-PAGE) and running buffers were purchased from Invitrogen-Life Technologies. 
All oligonucleotides were purchased from Integrated DNA Technologies. E. coli 5-alpha 
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cell line was purchased from Bioline. All other reagents and materials were purchased 
from Sigma-Aldrich unless otherwise stated.  
 
4.3.2 Library Construction 
The randomized RTX peptide library was constructed using two, overlapping 
oligonucleotides encoding for the entire gene. Randomized positions were created at the 
DNA level using degenerate codons. NNK bases were inserted at eight selected positions, 
forming a randomized face in the folded conformation. N represents any base, A, T, C or 
G. K represents the keto-containing bases, G or T. This codon stretch can code for all 20 
common amino acids while simultaneously knocking out two E. coli RNA stop codons, 
ochre (UAA) and umber (UGA). The library oligonucleotides were annealed and 
extended creating full-length, hybridized library. The C-terminal capping region was then 
added to the library by overlap extension PCR. All oligonucleotide sequences for the 
library construction and capping can be found in the Table S4.1. 
 
4.3.3 Selection of Mutants via Ribosome Display  
The capped RTX peptide library was sub-cloned into pRDV using KpnI and HindIII 
endonuclease restriction sites. The pRDV construct contains all of the genetic 
components required for cell-free transcription and translation including a T7 promoter 
and a ribosome binding site. The gene for an unstructured portion of the endogenous E. 
coli tolA protein lies directly downstream of the RTX library in pRDV (Fig. S4.1). The 
sole function of this protein is to act as a spacer and allow the translated RTX variant to 
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exit the ribosomal tunnel and fold in solution. Primers were designed to amplify the 
capped RTX library along with a portion of the tolA spacer (T7B and tolAK). A stop 
codon was excluded from this amplification to anchor the nascent protein and cognate 
mRNA strand to the ribosome. 
  250 ng of this PCR product was used as template for in vitro transcription and 
translation using the PURExpress system, according to the manufacturer’s protocol. A 25 
µL reaction was incubated for 1 hour at 37 °C and terminated by adding 475 µL of ice-
cold stop buffer (50 mM Tris–HCl, 150 mM NaCl, 0.1% (v/v) Tween 20, 2.5 mg/mL 
heparin, pH 7.5). The mixture was centrifuged at 14000 x g for 10 minutes to pellet 
insoluble reaction components. The soluble fraction was isolated and used immediately 
for selection. Simultaneously, 100 µL of biotinylated lysozyme (~350 µM) was 
immobilized on pre-blocked streptavidin coated microtiter plates for 1 hour on an orbital 
shaker at 4 °C. The wells were washed three times with ice-cold wash buffer (50 mM 
Tris–HCl, 150 mM NaCl, 0.1% (v/v) Tween 20, pH 7.5), and used immediately for 
selection experiments. 150 µL of the clarified translation mix was added to each well 
containing immobilized lysozyme. The calcium or magnesium concentration was 
adjusted to 25 mM to ensure the RTX peptide remained folded or unstructured, 
respectively, during the biopanning process. Selections were carried out for 1 hour at 4 
°C on an orbital shaker. Unbound and weakly associated clones were removed from the 
well by washing with 300 µL of ice-cold wash buffer supplemented with either 25 mM 
CaCl2 or MgCl2. For initial rounds of selection, fewer washes were used (~1-3). The 
stringency was increased for later rounds of selection in order to intensify the selective 
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pressure on the RTX library (~5-10). After the final wash, bound complexes were 
dissociated in 100 µL of elution buffer (50 mM Tris acetate, 150 mM NaCl, 25 mM 
EDTA, pH 7.5) for 5 minutes at 4 °C. The wells were washed with an additional 100 µL 
of elution buffer for 5 minutes at 4 °C to ensure high recovery. Recovered mRNA was 
purified on the QIAGEN RNeasy purification mini kit, according to the manufacturer’s 
protocol, and used as template for reverse transcription using the RETROscript reverse 
transcription kit. The resultant cDNA was used as template to amplify the selected library 
for cloning back into pRDV for a subsequent round of selection. Individual library 
variants were screened by transforming pRDV into 5-alpha E. coli, isolating single 
colonies on selective agar plates, and sequencing the extracted plasmid DNA. 
 
4.3.4 Cloning of Mutants into Expression Plasmids and Construction of 
Concatemers 
The genes coding for mutant peptides were cloned into pMAL-Intein backbone using the 
KpnI and HindIII restriction sites. For the concatemer construction, first mutant was 
cloned into the same vector via KpnI and HindIII sites, which did not have a stop codon 
at the C-terminus. The second mutant, with a stop codon at the end of the gene, was 
inserted via the HindIII site. For the triple mutant PN406-PN406-PN406, the third PN406 
was inserted via KpnI site into the pMAL-Intein-PN406-PN406 backbone. 10 amino acid 
linker GGGGSGGGGS was included in between the mutants. For affinity 
chromatography experiments, concatemers of WT β-roll and PN406 were genetically 
fused to N terminus of maltose binding protein (MBP). For the construction of MBP-WT-
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WT, the first WT β-roll was inserted via AvaI and EcoRI sites and the second one was 
inserted via EcoRI and BamHI sites, into the pMAL-c4e backbone. For MBP-PN406-
PN406, the concatemer was amplified out of the pMAL-Intein-PN406-PN406 plasmid 
and inserted into pMAL-c4e via AvaI and EcoRI sites. Resulting plasmids were 
transformed into 5-alpha cells. Corresponding primer sequences used during the PCR 
reactions are given in Table S4.1. 
 
4.3.5 Construction of Double Face Mutants  
For the construction of PN406/PN406, pMAL-Intein-PN406 plasmid was used as the 
template. Eight residues on the other face of the mutant were mutated to the residues of 
PN406 by performing site-directed mutagenesis via QuikChange II Site-Directed 
Mutagenesis Kit (Agilent), so that both faces of the β-roll contained the residues of 
PN406. For the construction of WT/PN406, pMAL-Intein-WTβ-roll plasmid was used as 
the template and eight residues on the opposite face were mutated to contain the PN406 
residues via site-directed mutagenesis. Corresponding primer sequences used for the PCR 
reactions are given in Table S4.2.  
 
4.3.6 Expression and Purification of WT and Mutant RTX Peptides 
The protein primary sequences of all peptides are given in Table S4.3. All constructs 
were expressed in 1 L of sterilized Terrific Broth supplemented with 100 µg/mL 
ampicillin, 2 g/L D-glucose and inoculated with 10 mL overnight culture. The cells were 
grown to an OD600 of 0.6 while shaking at 37 °C and protein expression was induced with 
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0.3 mM IPTG. Expression was carried out for 4-5 h at 37 °C. Cells were harvested by 
centrifugation at 5000 × g for 10 min and resuspended in 50 mL MBP column buffer (20 
mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, pH 7.4) per L of culture. For affinity 
chromatography experiments, modified MBP column buffer was used, which did not 
contain EDTA. Cells were lysed via sonication with an ultrasonication probe in ice bath 
for 6 min (5 s on pulse and 2 s off pulse). The lysed cell suspension was centrifuged at 
15000 x g for 30 min and the soluble fraction was collected. For the purification of all 
proteins in fusion with MBP-Intein, columns packed with amylose resin were used. The 
cell lysate was diluted to a volume of 200 mL, loaded onto equilibrated amylose columns 
and the columns were washed with the MBP column buffer. Then, the columns were 
saturated with intein cleaving buffer (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 
1.76 mM KH2PO4, 40 mM bis-Tris, 2 mM EDTA, pH 6.2), capped and incubated at 37 
°C for 16-20 h. Cleaved proteins were eluted with 50 mL of MBP column buffer. Amicon 
filters with 10 or 30 kDa molecular weight cutoff were used in order to concentrate the 
protein solutions as well as to buffer exchange into Q column low salt buffer (20 mM bis-
Tris, 25 mM NaCl, pH 6.0). The concentrated and buffer exchanged protein samples were 
loaded onto 16/10 Q FF ion exchange column (GE Healthcare). Target proteins were 
eluted using a linear NaCl gradient from 25 mM to 500 mM NaCl. Chromatography 
fractions were run on SDS-PAGE and pure fractions were combined and concentrated. 
For the affinity chromatography experiments, MBPTrap (GE Healthcare) columns were 
used. Cell lysates containing MBP fusion proteins were loaded onto the columns and the 
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columns were washed with the modified MBP column buffer to remove any other non-
specifically bound proteins. 
 
4.3.7 Circular Dichroism Spectroscopy  
Protein samples were buffer exchanged into 50 mM Tris, pH 7.4. 0.1 mm path length 
quartz cuvette was used to analyze the peptides. 100 µM samples were incubated with 10 
mM CaCl2 and were analyzed on a J-815 circular dichroism (CD) spectrometer (Jasco). 
Calcium titration (CaCl2 concentration varying between 0-10 mM) was performed with 
WT β-roll and PN406. The data were fit to the Hill equation using SigmaPlot software.  
 
4.3.8 Isothermal Titration Calorimetry  
All constructs were analyzed via MicroCal Auto-iTC200 in order to assess their binding 
parameters. In each experiment, 350 µM RTX peptide and 3.5 mM hen egg white 
lysozyme were used. The lysozyme was dissolved in 50 mM Tris, pH 7.4, modified with 
10 mM CaCl2 or MgCl2 and dialyzed against the same buffer, overnight prior to 
isothermal titration calorimetry (ITC) experiments. All experiments were carried out at 
25 °C. Titrations were conducted by 19 identical injections of 2 µL with duration of 4 s 
per injection and a spacing of 150 s between injections. The collected data were analyzed 
with the MicroCal Origin software supplied with the instrument to determine the binding 
constants via the one-site model. At least three ITC runs were performed for each 
construct. The resulting binding parameters were statistically analyzed via one-way 
ANOVA, where mutants were compared to either WT β-roll or concatenated WT-WT.  
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4.3.9 Affinity Chromatography Experiments  
The chromatography data presented involved two different constructs: MBP-WT-WT and 
MBP-PN406-PN406. Four MBP-Trap columns were used in total (two for each fusion 
protein for two different salt conditions). For all chromatography experiments, the assay 
buffer (MBP column buffer) did not contain any EDTA. Diluted cell lysates (5 mL) were 
loaded onto the columns after the columns were equilibrated with MBP column buffer. 
The columns were washed with 100 mL of MBP column buffer and equilibrated with 50 
mL of MBP column buffer modified with either 10 mM CaCl2 or MgCl2. After the 
equilibration, 1 mL of concentrated lysozyme solution (in the same modified MBP 
column buffer) was loaded onto the columns (accurate amounts: 4.37 and 4.60 mg for 
CaCl2 and MgCl2 runs, respectively). The columns were washed with 50 mL of modified 
MBP column buffer. Then, 100 mL of regular MBP column buffer (no calcium or 
magnesium) was run through the columns in order to wash away the ions and to elute the 
bound lysozyme. For FITC-labeled lysozyme experiments, the experimental set-up was 
the same as described above except columns pre-packed with amylose resin were used 
instead of the MBP-Trap columns. Columns were visualized under the UV light box to 
detect the FITC presence. For the specificity experiments, same amount of lysozyme was 
co-loaded with 200 or 1000 µL E. coli cell lysate. For these experiments, BL21(DE3) cell 
lines were grown and cell lysate containing E. coli proteins were obtained after sonication 
of the re-suspended cell pellets followed by centrifugation of lysed cells. Area under the 
curve calculations were done via Matlab software where the “trapz(x,y)” function was 
used to calculate the protein amounts. 
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4.3.10 Activity Assay of the Lysozyme 
Enzymatic activity of the eluted lysozyme fractions was assayed via Enzymatic Assay of 
Lysozyme kit following the manufacturer's instructions (Sigma-Aldrich). Briefly, a cell 
suspension (0.01 % (w/v)) was prepared by dissolving lyophilized Micrococcus 
lysodeikticus in the assay buffer (66 mM potassium phosphate buffer, pH 6.24). In a UV 
cuvette, 2.5 mL of the cell suspension was mixed with 0.1 mL of the lysozyme fraction to 




4.4.1 Mutation Positions and Library Generation 
The RTX domains of the adenylate cyclase protein from Bordetella pertussis and the 
location of the Block V domain are shown in Figure 4.1A. The peptide requires a C-
terminal capping group for proper folding into the β-roll secondary structure. It has a 
repetitive sequence rich in glycine and aspartic acid residues, which are responsible for 
providing flexibility in the turns and for calcium binding (Fig. 4.1B).18-20, 24-28, 37 The 
peptide is unstructured in the absence of calcium ions and folds into the β-roll structure 
upon calcium binding (Fig. 4.1C). In the folded state, the β-roll has two β-sheet faces. 
This results in 8 amino acids on each face with solvent exposed side chains (shown in 
green in Fig. 4.1B). The amino acids on one face of the peptide were randomized in order 
to create a library of new binding interfaces available to interact with target molecules 
when the peptide is in the folded conformation (Fig. 4.1C). The degenerate NNK codon 
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was used at the 8 positions to produce a library size of 208 possible mutant Block V 
peptides. 
 
Figure 4.1 The structure of the β-roll peptide and library positions. (A) Adenylate 
cyclase enzyme has five (RTX) domains, which start with the amino acid residue at 
position 1009. The β-roll (blue) and its capping group (grey) are located between residues 
1529 and 1680. The bound calcium ions are shown in red. (B) Protein structure and 
primary sequence of the peptide. Eight residues on the face of the β-roll are highlighted in 
green. These positions (shown as X’s in the protein sequence) were randomized in the 
created library. All figures were rendered in PyMOL using PDB file 5CVW. (C) Cartoon 
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demonstrating the switch mechanism of the peptide. It transitions from its unstructured 
state to the β-roll structure upon calcium binding (red). Calcium-triggered folding results 
in the formation of the binding interface (green) and the folded peptide captures the target 
(orange). 
 
4.4.2 Library Selection Using Ribosome Display  
The capped RTX Block V library was subcloned into the pRDV vector38 for selection via 
ribosome display. A description of the selection protocol is given in Section 4.3.3. Cell-
free transcription and translation of the DNA library has been described previously.38, 39 
Exclusion of a stop codon in the library transcripts allowed for the generation of ternary 
complexes composed of ribosomal subunits, mRNA, and the cognate translated protein, 
thereby maintaining a genotype-phenotype linkage (Fig. S4.1). These complexes were 
used to select for clones that exhibited affinity towards immobilized biotinylated-
lysozyme. Selections were performed in the presence of calcium to enable folding of the 
RTX domain. 
 Consecutive rounds of biopanning in the presence of 10 mM calcium were 
performed starting with the naïve library. After six rounds of selection, the enriched 
library was transformed into E. coli and individual variants were sequenced. Out of 10 
sequenced variants, 6 contained full-length sequences and 4 of these 6 variants converged 
to a single, consensus sequence: P101 (P stands for positive selections) (Table S4.4). This 
clone was moved into an expression vector and characterized.  
132 
!
A parallel selection approach was used to enrich the same naïve library for 
lysozyme binders using intermittent negative selections. Following two rounds of 
biopanning in 10 mM calcium, the library was subjected to negative selection in 10 mM 
magnesium, which does not induce β-roll formation in the native sequence. For the 
negative selections, the unbound material was recovered and used for subsequent rounds 
of selection. Two more positive selections and a final negative selection were performed 
on this library. After the final round of selection, convergence was not observed in 35 
sequenced RTX variants and out of these, 10 mutants were selected for further 
evaluation. Mutants with proline residues were assumed to be detrimental to the 
conformational change of the peptide and were avoided.28, 40 Priority was given to 
mutants rich in charged and hydrophobic residues, which frequently occupied mutated 
positions throughout the library. The 10 selected variants were subcloned into an 
expression vector and characterized (Table S4.5).    
 
4.4.3 Determination of Binding Parameters  
After obtaining pure recombinant proteins (Fig. S4.2A), the interactions of the wild-type 
and mutant peptides with lysozyme were quantified using ITC. The mutant with the 
converged sequence, P101, as well as three other mutants from the positive/negative 
selections, PN206, PN406 and PN715 bound to lysozyme with an order of magnitude 
lower dissociation constants (Kd’s) compared to wild-type β-roll in the presence of 
calcium (Table 4.1). The number of binding sites varied between 0.45 and 0.85 (where 
0.5 would indicate 2 RTX domains per one lysozyme molecule).  
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 The mutant with the highest affinity, PN406, was found to bind lysozyme with a 
Kd of 2.3 µM. The one-way ANOVA analysis revealed a statistically significant 
difference for the Kd’s of all mutants compared to the wild-type peptide whereas the 
number of binding sites did not show a significant difference. Control experiments were 
performed in the presence of magnesium, where the β-roll structure is not expected to 
form. Even though some reproducible temperature changes were observed upon 
lysozyme titration, the results were not comparable to what was observed with calcium 
and the data could not be fitted to yield binding parameters (Fig. S4.3). Of the 10 
candidates investigated from the positive/negative selections, 7 were found to either 
behave similarly compared to wild-type β-roll or not demonstrate affinity for the target 
(Fig. S4.4). 
 
4.4.4 Characterization of Identified RTX Block V Mutants  
The responsiveness of the mutants to calcium was investigated by CD spectroscopy. 
Figure 4.2A shows the CD spectra of the wild-type and the mutant peptides in the 
absence of calcium and the spectra in the presence of 10 mM CaCl2 are shown in Figure 
4.2B. In the absence of calcium, the CD spectra exhibited a large negative peak at 198 nm 
for all constructs, indicating a lack of secondary structure (Fig. 4.2A). In the presence of 
calcium, the minima shifted to 218 nm, indicating the transition from unstructured 
peptide to β-sheet structure for every mutant (Fig. 4.2B). For the wild-type and the 
PN406 mutant peptides, calcium titrations were performed up to 10 mM CaCl2 (Fig. 
4.2C). The data were fit to the Hill equation to determine the calcium binding parameters 
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(Fig. 4.2D). PN406 bound calcium with a similar affinity compared to the wild-type and 
Hill coefficients greater than 1 indicated cooperative binding between the peptides and 
the calcium ions. 








The values are reported as mean ± SEM (n=3). Statistically significant differences are 




 (µM) N 
WT 33 ± 10 0.46 ± 0.10 
P101 3.2 ± 0.7* 0.55 ± 0.09 
PN206 6.2 ± 2.5* 0.49 ± 0.08 
PN406 2.3 ± 0.3* 0.76 ± 0.03 




Figure 4.2 Characterization of β-rolls with circular dichroism spectroscopy (CD). 
Mean residue ellipticity (MRE) was recorded over a range of wavelengths for wild-type 
as well as mutant RTX sequences (A) in the absence and (B) in the presence of 10 mM 
CaCl2. (C) Recorded relative MRE (at 218 nm) at different calcium concentrations for 
wild-type RTX and PN406. (D) The data were fit to the Hill equation using nonlinear 





4.4.5 Combined Binding Interfaces for Improved Apparent Affinity 
To improve lysozyme binding, combined β-roll interfaces were explored. A concatemer 
of PN406 was created by fusing the same genes in series: PN406-PN406. The binding 
surface area was further increased by inserting a third PN406 gene to this construct: 
PN406-PN406-PN406. Four additional concatemers were created by fusing the single 
mutants PN206 and PN715 to PN406. In addition, the opposite face of the folded β-roll 
was explored by mutating the eight residues on the back face to contain the amino acid 
residues of PN406: PN406/PN406. The resulting mutant had the same mutations on both 
faces. Lastly, the binding suitability of the back face of the β-roll was explored by itself. 
The eight residues on the front face of PN406/PN406 were reverted back to the wild-type 
residues: WT/PN406. Illustrations of the designed tertiary structures are shown in Figure 
4.3A with their mutated residues presented in green. The concatenated and double-face 
mutants were analyzed via ITC. For all β-roll mutants, the change in the Gibbs free 
energy of binding upon interaction with lysozyme was calculated (Fig. 4.3B, Table S4.6). 
The largest difference was observed in PN406-PN406 (-10.1 kcal/mol), followed by 
triple-PN406 (-9.4 kcal/mol). The raw and fitted ITC data for wild-type, PN406 and 
PN406-PN406 are presented in Figures 4.3C, D and E, respectively. Control experiments 
were performed in the presence of magnesium and no binding signal was observed. The 
raw ITC data of PN406-PN406 in the presence of magnesium is shown in Figure S4.3C.  
 The binding parameters of the combined β-roll mutants are reported in Table 4.2. 
The concatemers of PN406 and PN715 exhibited apparent dissociation constants of 1.0 
and 1.3 µM whereas concatemers of PN206 and PN406 exhibited apparent Kd’s in the 
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high nanomolar range (514 nM for PN206-PN406 and 122 nM for PN406-PN206). The 
mutant with highest avidity was found to be PN406-PN406 with an apparent dissociation 
constant of 65 nM and the insertion of another PN406 to this construct (PN406-PN406-
PN406, Kd,apparent: 155 nM) did not further improve the avidity. Compared to the 
concatemer of the wild-type β-roll (WT-WT), one-way ANOVA analysis of the apparent 
Kd values revealed a statistically significant difference for PN206-PN406, PN406-PN406, 
PN406-PN206 and PN406-PN406-PN406. The double-face mutants PN406/PN406 and 
WT/PN406 bound to lysozyme with Kd values of 3.1 and 34 µM, respectively. The 
number of binding sites varied between 0.57 and 1.17 for the β-roll mutants with 
increased binding surface areas. Compared to WT-WT, the one-way ANOVA analysis of 















Figure 4.3 Lysozyme binding characteristics of RTX domains in the presence of 
calcium. (A) Illustrations of the designed tertiary structures of mutants genetically 
constructed based on PN406. The mutated residues are shown in green. Calcium ions and 
the linker between concatamers are shown in red and yellow, respectively. PN406/PN406 
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has the mutated residues on both faces and WT/PN406 has mutated residues only on the 
opposite face. PN406-PN406 and PN406-PN406-PN406 are the concatenated mutants. 
(B) Changes in the Gibbs free energy upon interacting with lysozyme. The error bars 
denote the SD (n=3). (C) - (E) ITC data for titration of lysozyme into wild-type β-roll, 
PN406 and PN406-PN406. The raw data are presented in the upper panels and bottom 
panels show the integrated data fitted via one-site binding model. 













The values are reported as mean ± SEM (n=3). Statistically significant differences are 
denoted with * (one-way ANOVA, p < 0.05). 
 
Peptide Kd,apparent N 
WT-WT 1.4 ± 0.5 µM 0.80 ± 0.04 
PN206-PN406 514 ± 155 nM* 0.57 ± 0.13 
PN406-PN206 122 ± 42 nM* 0.58 ± 0.03 
PN406-PN406 65 ± 28 nM* 0.79 ± 0.04 
PN406-PN715 1.3 ± 0.2 µM 1.07 ± 0.03 
PN715-PN406 1.0 ± 0.2 µM 1.12 ± 0.11* 
PN406-PN406-PN406 155 ± 54 nM* 1.05 ± 0.08 
PN406/PN406 3.1 ± 0.3 µM* 1.17 ± 0.06* 
WT/PN406 34 ± 10 µM 0.82 ± 0.01 
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4.4.6 In vitro Demonstration of Allosteric Regulation via Affinity Chromatography 
To demonstrate the utility of the selected β-roll peptides, affinity chromatography 
experiments were performed. The concatemer of PN406 was fused to maltose binding 
protein (MBP), was immobilized on columns and binding of lysozyme was assessed in 
the presence of either calcium or magnesium. A schematic of the chromatography 
experiments is shown in Figure 4.4A. Following target loading, columns were washed for 
10 column volumes (CVs, 1 CV = 5 mL) with buffer modified with calcium or 
magnesium. Subsequently, the columns were washed for 20 CVs (100 mL) with regular 
column buffer, which did not contain calcium or magnesium. The same experiments were 
repeated with the WT-WT fused to MBP, as a negative control. 
 Figure 4.4B shows chromatography data for both constructs, in the presence of 
either calcium or magnesium. For the WT-WT construct, the loaded lysozyme was eluted 
during the column wash, independent of the salt composition. A similar chromatogram 
was obtained for PN406-PN406 when the experiment was performed with MgCl2. 
However, this mutant captured the lysozyme in the presence of CaCl2 and the majority of 
the target was eluted upon the switch in the column buffer (Fig. 4.4B). Area under the 
curve analysis showed that, at the peak fractions, the recovered lysozyme amount was 75 
% for MBP-WT-WT/Mg++, 78 % for MBP-WT-WT/Ca++ and 74 % for MBP-PN406-
PN406/Mg++. In the case of MBP-PN406-PN406/Ca++, 26 % of the loaded lysozyme was 
lost during the washing step and the area under the peak fractions corresponded to 53 %. 
Within the first 50 mL (10 CVs) of the elution step, 66 % of the loaded lysozyme was 
recovered. Chromatography peak fractions were analyzed via sodium dodecyl sulfate 
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polyacrylamide gel electrophoresis (SDS-PAGE) and the resulting bands corresponded to 
lysozyme, which has a molecular weight of 14.3 kDa. Identical experiments were 
performed with fluorescein isothiocyanate (FITC)-labeled lysozyme (Fig. 4.4C). After 
washing the columns for 10 CVs (50 mL), the columns were visualized under UV light to 
detect the FITC label. Only PN406-PN406 was capable of retaining the target, in the 
presence of calcium. To test the recyclability of the capture and release, the same column 
was used for three rounds of target loading and elution. The bottom panel in Figure 4.4C 
shows three successive cycles of target capture and release in the same column.  
 Lastly, the selectivity of the interactions between PN406-PN406 and the lysozyme 
was investigated. Similar affinity chromatography experiments were performed where 
lysozyme was mixed with E. coli crude cell lysate (200 or 1000 µL). As demonstrated in 
Figure 4.4D, E. coli proteins eluted within the first 25 mL (5 CVs) of the column washes. 
Purified lysozyme eluted after the calcium ions were eliminated (following the switch in 
the column buffer). Chromatography peak fractions were analyzed via SDS-PAGE. Lane 
6 in the resulting gel picture shows the eluted purified lysozyme whereas the peak 
fraction of the column wash containing the non-specific E. coli proteins is shown in lane 
5 (Fig. 4.4D). In the case of the 1000 µL cell lysate, a purification factor of 14.7 was 
achieved for active lysozyme (Fig. 4.4B and D, Fig. S4.5), which is comparable to 






Figure 4.4 Calcium-triggered capture and release of lysozyme. (A) Cartoon 
representation of the affinity chromatography experiments. PN406-PN406 mutant was 
genetically fused to maltose binding protein (MBP) and immobilized on resin. In the 
presence of magnesium, the mutant peptides remain unstructured. In the presence of 
calcium (middle panel) the β-rolls fold and retain the target molecule on the column. The 
last panel shows the elution step where the calcium ions are washed away. The β-rolls 
transition to their unfolded state, losing interaction with the target. (B) Affinity 
chromatography experiments performed with immobilized MBP-WT-WT and MBP-
PN406-PN406. The absorbance at 280 nm was recorded for four different runs: each 
protein was tested in the presence of calcium or magnesium. After lysozyme loading, the 
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columns were washed with buffer containing 10 mM CaCl2 or MgCl2. Elution was 
performed using buffer without Ca++ or Mg++. The lysozyme was eluted during the 
column wash for WT-WT/Mg++, WT-WT/Ca++ and PN406-PN406/Mg++. Lysozyme was 
eluted from PN406-PN406/Ca++ only after calcium was removed. The SDS-PAGE gel 
picture shows the samples taken from the peak fractions of each curve; the molecular 
weight of lysozyme is 14.3 kDa. (C) Identical experiments were performed with FITC-
labeled lysozyme, loaded in the presence of calcium or magnesium. Column pictures 
were taken under UV-light after the column wash to detect any FITC presence. The 
picture on the right in the top panel shows the lysozyme captured by PN406-PN406 in the 
presence of calcium. The bottom panel presents the capture and release cycles conducted 
with the same column. (D) Affinity chromatography experiments performed with 
immobilized MBP-PN406-PN406 where lysozyme was mixed with E. coli crude cell 
lysate and column wash and target elution steps were performed as in panel (B). PN406-
PN406 captured the lysozyme in the lysate matrix. The gel picture presents the samples 
taken from the peak fractions. Lane 5 shows the E. coli proteins, which did not bind to 




Directed evolution techniques have enabled the development of alternative molecular 
recognition scaffolds that can rival the performance of antibodies.  There is also a great 
interest in conformationally-dynamic systems, e.g. protein switches42-44 which allow for 
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new control mechanisms over protein function. In this work, we combined these concepts 
and demonstrated the selection of biomolecular recognition functionality in an 
allosterically-regulated peptide scaffold. 
 An advantage of using repeat scaffolds for molecular recognition is that the 
binding interface can be localized to a few amino acids in the repetitive sequence on the 
scaffold, making it easier to construct randomized libraries with defined surfaces for 
molecular recognition. In nature, the LRR repeat scaffold is used instead of 
immunoglobulin domains in the adaptive immune systems of some jawless vertebrates 
(e.g. hagfish and lampreys).45 We have identified two of the nine amino acids in the 
canonical β-roll peptide sequence that are not involved in turn formation, calcium 
binding, or creation of the hydrophobic core. These two amino acids are highly variable 
in all RTX domains, and are generally solvent exposed.24, 25, 28, 34 This creates an 
opportunity to vary these pairs of amino acids for desired new functionalities without 
compromising the unique and specific environmentally responsive behavior of the 
scaffold. The Block V RTX domain from adenylate cyclase has 4.5 turns (Fig. 4.1B). 
During the library generation, only the 8 amino acids on the 4 full turns on one face of the 
peptide were randomized. This allowed all mutants to retain the ability to adopt the β-roll 
structure in the presence of calcium, decoupling the amino acids involved in structure 
formation from those involved in molecular recognition. 
 Selection techniques are critical for combinatorial protein engineering processes. 
Previously, we explored bacterial cell surface display and monovalent phage display as 
methods to form a genotype-phenotype linkage. However these techniques proved to be 
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difficult to use with the RTX domains. After several rounds of selection, frameshifts and 
stop codons within the β-roll sequences frequently accumulated. Ribosome display is not 
limited by the bacterial cell transformation efficiency and eliminates issues with clonal 
selection. Thus this method was used and found to be more robust, enabling the 
reproducible selection of full-length sequences from the RTX peptide library (Fig. S4.1). 
 Multiple rounds of positive selections readily converged to the sequence of P101. 
In order to further explore the library, iterative positive/negative selections were 
performed and interestingly this approach did not converge to a dominant sequence. After 
analyses of 10 selected mutants via ITC, three mutants were identified with improved 
affinities: PN206, PN406 and PN715, and the Kd values of these three mutants were 
similar to the P101 mutant (Table 4.1). It remains to be seen whether this is the maximum 
affinity that can be achieved by selection of this peptide library and whether further 
improvement is not being selected. However it may be possible that this is the maximum 
binding interaction that can be obtained between lysozyme and the 8 randomized amino 
acids as located on the front face of the β-roll scaffold. It is also probable that 
positive/negative selections did not converge because there are several mutants in the 
library with similar affinities, which were possibly being co-selected together.  
The ITC signals of the RTX peptides in the presence of magnesium were of 
unexpected character. The observed temperature changes suggested an interaction, 
however the data could not be fitted to yield binding parameters. We and others have 
extensively characterized the calcium-dependent folding of the Block V RTX domain 
using CD, Bis-ANS dye binding, quartz crystal microbalance (QCM) and FRET 
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experiments with appended fluorescent proteins18, 28, 34. The addition of magnesium is 
used as the negative control, as it does not induce the β-roll secondary structure 
formation.34 Therefore it is unlikely that that the RTX domains were folding in the ITC 
experiments with magnesium. Since the signals were all very similar, and independent of 
the mutations, it seems likely that these interactions were happening at the non-
randomized amino acid positions. With the concatemers, the ITC signals with magnesium 
subsided significantly, to the point where the integrated heat pulse data points seemed to 
be random (Fig. S4.3C).  
The calcium-responsiveness of the RTX mutants was characterized via CD and 
we observed that the responses to calcium were largely unaffected by the mutations (Fig. 
4.2A and B). The CD results were similar to what we observed with the same 8 residues 
mutated to leucine amino acids.34 These results suggest that probably any amino acid 
besides proline can be tolerated at these positions without affecting the calcium-
dependent conformational behavior of the RTX scaffold. The mutant with highest 
affinity, PN406, was further characterized by calcium titration. The wild-type peptide and 
PN406 mutant bound calcium with similar affinities and both exhibited cooperative 
binding as demonstrated by their Hill coefficients (Fig. 4.2C and D).  
Unraveling affinity calculations is complicated when multiple binding sites are 
involved. Multiple copies of a binding interface can introduce an avidity effect leading to 
a higher apparent affinity and this was explored by concatenating different RTX mutants. 
Even though the single mutants had similar affinities, different combinations of them led 
to significant differences in overall binding parameters. The concatemer with highest 
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affinity was found to be PN406-PN406, which bound lysozyme with an apparent 
dissociation constant of 65 nM. The number of binding sites did not drastically change 
upon concatenation (Table 4.2). Since lysozyme is able to form dimers, 46, 47 it is not clear 
if the improvement is due to avidity effects or due to binding of the dimeric form of the 
target enzyme. The latter case could explain why the addition of a third PN406 does not 
improve the avidity any further. It is interesting to note that the order of the mutants in 
the concatemers is of importance as demonstrated by the difference in avidities of 
PN206-PN406 and PN406-PN206.    
 The β-roll domains appear to be symmetrical by inspection of their primary 
sequences, such that amino acids project out radially from faces on both sides of the β-
roll domain (Fig. 4.1B). By placing the mutant amino acids on the backside of the 
domain, we explored if the binding face could be transplanted (Fig. 4.3A). This strategy 
did not work, as the binding affinities were not changed (Table 4.2). Similar dissociation 
constants were observed for WT/PN406 and wild-type β-roll and for PN406/PN406 and 
PN406, suggesting that the residues on the other face of the peptide did not contribute to 
the overall interaction. This is likely due to the fact that the two faces of the peptide are in 
fact not symmetrical (Fig. 4.1B). The second face of the β-roll has a more concave 
structure compared to the other face, which has a more planar surface. The capping group 
is also not symmetrical and could add steric hindrance on the backside of the β-roll that 
prevents lysozyme binding by the selected amino acids.   
The differences in the Gibbs free energy of binding showed that the single mutant 
constructs added 1-1.5 kcal/mol whereas this amount doubled for most of the 
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concatemers (1.9-2.5 kcal/mol) except for PN406-PN206, PN406-PN406 and PN406-
PN406-PN406 which had energy changes of 3.4, 3.9 and 3.2 kcal/mol, respectively (Fig. 
4.3E), demonstrating the effects of avidity upon concatenation. The energy change of 
WT/PN406 was the same as the wild-type peptide and PN406/PN406 had a similar 
change of 1.4 kcal/mol, when compared to PN406 (1.5 kcal/mol). These energy changes 
are on the order of either a single new interaction, such as a hydrogen bond, an 
electrostatic or a hydrophobic interaction, or several van der Waals interactions. Among 
the 8 mutations, positions 1, 3, 4 and 5 were dominated by the hydrophobic residues (Fig. 
S4.6).  
 Allosterically-controlled biomolecular recognition scaffolds should provide 
benefits for many biotechnology applications. To demonstrate this utility, in this work the 
β-roll mutant with the highest affinity was utilized in the “catch and release” affinity 
chromatography purification of lysozyme. The results of this experiment showed that 
PN406-PN406 was capable of forming sufficient interactions with its target to capture it 
on the affinity column in the presence of calcium. The captured lysozyme was easily 
eluted upon removal of calcium ions, when the mutant transitions to its unfolded state. In 
most of the affinity-based approaches, target elution can be challenging. For example, in 
immunochromatography methods, large pH swings or high concentrations of chemical 
denaturants are required to disrupt the interactions between the target and the antibody.48, 
49 The use of the engineered RTX peptide provides an easy elution step by taking 
advantage of environmental control over the structure of the scaffold. The Kd of the β-roll 
for calcium (~1 mM) allows the elution of the target without the need for a chelator. In 
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addition, the results shown in Figure 4.4C demonstrate the re-usability of this catch and 
release platform as the binding interface can be regenerated and reused. The allosteric 
regulation of the RTX domain serves as a switch for turning the binding on and off. 
Future RTX mutants can be engineered to bind additional targets, creating a new 
approach to affinity chromatography. This will be of great interest in the bio-separations 
area as well as other areas of biotechnology where binding events need to be easily and 















4.6 Supplementary Information 
4.6.1 Supplementary Figures 
 
Figure S4.1 Schematic of the ribosome display selection method. After cloning the 
RTX library into the ribosome display vector (pRDV), the library was transcribed and 
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translated in vitro. Resulting complexes were incubated with the immobilized target. The 
mRNA of the bound complexes was reverse transcribed and PCR amplified to serve as 
the input for another round of selection.50  
 
 
Figure S4.2 SDS-PAGE analysis of WT and mutant peptides. (A) (1) Protein ladder. 
(2) WT β-roll: 15.9 kDa. (3) P101: 16 kDa. (4) PN206: 16.0 kDa. (5) PN406: 15.8 kDa. 
(6) PN715: 15.9 kDa. (B) (1) Protein ladder. (2) WT-WT: 32.7 kDa (3) PN206-PN406: 
32.7 kDa. (4) PN406-PN406: 32.6 kDa. (5) PN406-PN206: 32.7 kDa. (6) PN406-PN715: 
32.5 kDa. (7) PN715-PN406: 32.5 kDa. (8) PN406-PN406-PN406: 49.2 kDa. (9) 
WT/PN406: 16.0 kDa. (10) PN406/PN406: 15.9 kDa. We have previously shown that β-
rolls run artificially large on SDS-PAGE.34 In addition, peptide hydrophobicity has been 
shown to result in gel shifting, which can cause the differences in the apparent molecular 






Figure S4.3 Exemplary ITC analysis of  (A) wild-type β-roll, (B) PN406 and (C) 










Figure S4.4 Exemplary ITC analysis of PN316 and PN708 in the presence of 10mM 
CaCl2.  (A) PN316 did not demonstrate an affinity for the target. (B) PN708 bound 




Figure S4.5 Activity assay of the eluted lysozyme. (A) Lysozyme eluted off the MBP-
PN406-PN406/Ca++ column. The decrease in the absorbance at 450 nm indicates the 
activity of the enzyme. (B) Lysozyme eluted off the MBP-PN406-PN406/Ca++ column, 
which was co-loaded with E. coli crude cell lysate. The decrease in the absorbance at 450 






















4.6.2 Supplementary Tables 
Table S4.1 PCR primers for cloning experiments 
Cloning 













































T7B 5’ ATACGAAATTAATACGACTCACTA TAGGGAGAC CACAACGG 3’ 
tolAK 5’ CCGCACACCAGTAAGGTGTGCGGTTTCAGTTG CCGCTTTCTTTCT 3’ 
P101, PN206, 
PN406 and PN715 
into pMAL-c4e-
Intein 
Forward 5’ AATAATGGTACCGGGTTCTGCACG CGACGATGTGC 3’ 





























































fusion with MBP 







Table S4.2 PCR primers for site-directed mutagenesis experiments 
Construct Primer Sequence 
WT/PN406 
1 5’ CGCGCGTGATGACTCGCTGGTCGGC 
GACGCAGG 3’ 
2 5’ GCGGGCAACGACTTGCTGTTAGGCG GCGCTGGC 3’ 
3 5’ CGGGCAGGGCGATGATAGGTATCTG TTCGGGGT 3’ 
4 5’ GAGGGCTCGGACGTGCTCGACGGCG ATGCGGG 3’ 





1 5’ GGGTTCTGCACGCGACGATTCGCTG 
GTCGGCGACGC 3’ 
2  5’ GGCTGGTAACGACCTCTTGTTAGGT GGTGCGGGCG 3’ 
3 5’ GACGAGGGCTCCGATGTGCTGGACG GTGATGCCGG 3’ 
4 5’ CGGTCAGGGCGACGATAGGTACCTG TTCGGTG 3’ 















































































































* Blue and black residues represent the β-roll domain and the capping group respectively. 
Red residues represent the residues on the β-roll faces. Light grey residues represent the 
linker. 
Table S4.4 Sequencing results of the positive selections 
Mutant Amino acids at randomized positions Frequency 
P101 W F L E A T D A 4/6 
P105 L Y R Q A T D A 1/6 



















Table S4.5 Selected mutants of the positive/negative selections 
Mutant Amino acids at the randomized positions 
PN101 G M G W G N V W 
PN112 V L G V Q D Q A 
PN118 A R A V A D T A  
PN206 V R W W V C S R  
PN311 V E R A E R T V  
PN316 A R R V E R T V  
PN406 S V L L V D R V  
PN614 E S L L C S G G  
PN708 R R G V T D R A  














Table S4.6 The changes in the Gibbs free energy upon interaction with lysozyme 
Peptide ΔG (kcal/mol)* 
WT -6.2 ± 0.3 
PN101 -7.5 ± 0.2 
PN206 -7.2 ± 0.4 
PN406 -7.7 ± 0.2 
PN715 -7.2 ± 0.6 
WT-WT -8.1 ± 0.5 
PN206-PN406 -8.6 ± 0.3 
PN406-PN206 -9.5 ± 0.5 
PN406-PN406 -10.1 ± 0.8 
PN406-PN715 -8.0 ± 0.1 
PN715-PN406 -8.2 ± 0.2 
PN406-PN406-PN406 -9.4 ± 0.3 
PN406/PN406 -7.5 ± 0.1 
WT/PN406 -6.2 ± 0.3 
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Smart, Bi-Functional Hydrogels via Stimulus-
Responsive β-roll Domains † 
!
5.1 Abstract 
Stimulus-responsive hydrogels have applications in many biotechnology areas, such as 
tissue engineering, drug delivery and bioelectrocatalysis. The presented work offers a 
hydrogel platform, which combines calcium dependent network formation and target 
molecule entrapment. The β-roll mutant with hydrophobic interfaces (DLeu β-roll) is 
genetically fused to the lysozyme capturing β-roll mutant (406 β-roll), resulting in a 
stimulus responsive hydrogel with dual functionality. This way, the calcium induced 
control over the secondary structure of the β-roll peptide is demonstrated to allosterically 
regulate both the cross-linking and the lysozyme binding properties. The constructed 







† A version of this chapter is being prepared for publication with co-author Scott Banta. B.B. 
designed the experiments, cloned and characterized all constructs, prepared hydrogel samples, 
performed lysozyme capture and hydrogel erosion rate experiments. 
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5.2 Introduction 
The potential applications of stimulus-responsive hydrogels are discussed in Section 3.2. 
Briefly, there has been a great interest in the development of new hydrogel platforms, 
especially in the area of tissue engineering and drug delivery. Some of the potential 
applications include cell entrapment and delivery, where the gel formation is achieved 
after the subcutaneous injection of the hydrogel samples; cell culture, where cells are 
embedded within the gels under certain conditions for the manipulation of the cell 
behavior; drug delivery, where hydrogels form via different stimuli such as changes in 
the pH or temperature and sustained delivery of entrapped therapeutics can be achieved; 
and enzymatic applications, such as electrode modifications for bioelectrocatalysis.1-9 
 In our previous work (Chapter 3), we demonstrated that a mutant version of the β-
roll peptide10-15, DLeu β-roll, can be used as a stand-alone cross-linking moiety, where 
the network formation can be controlled by calcium addition. This peptide has two 
hydrophobic faces, rich in leucine residues, which come together with other mutant 
peptides and actuate self-assembly in its folded state.16 In another work (Chapter 4), the 
same peptide was evolved to bind to lysozyme. A mutant version of the β-roll was 
identified, 406 β-roll, which binds the target molecule with mid-nanomolar affinity upon 
concatenation. The binding behavior between the mutant peptide and lysozyme can be 
controlled by adjusting the calcium concentrations as well.17 
 In the present study, a new hydrogel platform is constructed based on these two 
different versions of the β-roll peptide (Fig. 5.1). This dual-functional, smart, stimulus-
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responsive hydrogel can capture lysozyme on its surface and both oligomerization and 
target-capturing properties can be controlled via calcium addition. As the control group, a 
second construct is cloned where the concatemer of 406 β-roll is replaced with the 
concatemer of wild-type β-roll.  
 
Figure 5.1 Constructed hydrogel platforms. The top panel shows the hydrogel 
construct composed of network forming domains and the concatemer of wild-type β-roll. 
The bottom panel shows the construct composed of cross-linking domains and the 
concatemer of lysozyme binding 406 β-roll. The lysozyme molecules are demonstrated in 
orange. Each construct has a N-terminal maltose binding protein (MBP) for expression 
and purification purposes. 
  Previously, it was shown that the concatemer of wild-type β-roll has an affinity 
for lysozyme in the low-micromolar range. This construct was found to be unable to 
capture the target molecule during affinity experiments.17 More than two orders of 
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magnitude difference was observed in the affinity of the concatemer of the 406 β-roll and 
of the wild-type β-roll, for lysozyme. As such, it is expected to see a difference in the 
target interaction capabilities between the two hydrogel constructs. In order to probe this 
proposition, hydrogel samples with both constructs were prepared. Individual hydrogel 
building domains were characterized via circular dichroism to investigate the calcium-
binding responsiveness of the mutant peptides. In order to determine the lysozyme 
binding and entrapping capacities, target retention and erosion rate experiments were also 
performed. This way, the unique functionality of the concatemer of the 406 β-roll was 
integrated into this smart biomaterial, which could actualize calcium dependent cell lysis. 
This component of the hydrogel construct can be easily replaced with other proteins with 
other functionalities or different β-roll mutants demonstrating affinities towards other 
targets. 
 
5.3 Materials and Methods 
5.3.1 Plasmids and Chemicals 
The wild-type block V RTX domain with its capping group was amplified out of pDLE9-
CyaA as described before.16, 18 Amylose resin and enzymes used in gene cloning were 
purchased from New England Biolabs. Oligonucleotides used for cloning experiments 
were synthesized by Integrated DNA Technologies. E. coli 5-alpha cell line was 
purchased from Bioline. Terrific broth media for protein expression and FITC-labeled 
lysozyme were purchased from Thermo Fisher Scientific. Ampicillin sodium salt and 
isopropyl β-D-1-thiogalactopyranoside (IPTG) were purchased from Gold 
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Biotechnology. Amicon centrifugal filters were purchased from Millipore. Sodium 
dodecyl sulfate polyacrylamide electrophoresis gels (SDS-PAGE) and gel running 
buffers were purchased from Invitrogen-Life Technologies. All other chemicals used in 
purification and assay buffers were purchased from Sigma-Aldrich. 
 
5.3.2 Construction of Hydrogel Plasmids 
Construction of the hydrogel forming β-roll mutant (DLeu β-roll) and lysozyme binding 
β-roll mutant (406 β-roll); cloning of the concatemer of 406 β-roll and wild-type β-roll 
were described previously. For individual characterization, each construct was cloned 
into pMAL-Intein backbone as described before.16, 17  
 For the MBP-DLeuβ-WTβ-WTβ-DLeuβ hydrogel construct, a previously 
constructed vector was used: pMAL-MBP-DLeuβ-GFP-DLeuβ. The GFP was replaced 
by the concatemer of the wild-type β-roll via BamHI and SalI restriction sites. For the 
cloning of the second hydrogel construct (MBP-DLeuβ-406β-406β-DLeuβ), concatemer 
of the 406 β-roll was inserted into the same backbone via the same sites. Resulting 
plasmids were transformed into 5-alpha cells. The primers used in these cloning 
experiments are given in Table S5.1.  
 
5.3.3 Expression and Purification of Hydrogel Constructs 
The protein primary sequences of all peptides are given in Table S5.2. Both hydrogel 
constructs as well as single β-roll components were expressed in 1 L of sterilized Terrific 
Broth supplemented with 100 µg/mL ampicillin, 2 g/L D-glucose and 10 mL overnight 
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culture, at 37 °C. The cells were grown to an OD600 of 0.6 while shaking and protein 
expression was induced with 0.3 mM IPTG. Expression was carried out for 5-7 h at 37 
°C. After cell harvest, the single β-roll components were purified as described 
previously.16, 17 To purify the hydrogel proteins, the cells were resuspended in 50 mL 
MBP column buffer (20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, pH 7.4) per L of 
culture and amylose columns were used after cell lysis with an ultrasonication probe in 
ice bath for 6 min (5 s on pulse and 2 s off pulse). After sample loading, the columns 
were washed with 100 mL of MBP column buffer, followed by the elution of the 
hydrogel constructs via 25 mL of buffer containing maltose (20 mM Tris-HCl, 200 mM 
NaCl, 1 mM EDTA, 10 mM Maltose, pH 7.4). Eluted proteins were concentrated via 50 
kDa molecular weight cutoff amicon filters and buffer exchanged into size exclusion 
chromatography (SEC) buffer (50 mM Tris, 150 mM NaCl, pH 7.4). Concentrated 
protein samples were run on SEC column as the last purification step. Chromatography 
fractions were run on SDS-PAGE, pure fractions were combined, concentrated and buffer 
exchanged into 5 mM Tris, pH 7.4. SDS-PAGE analysis of the purified MBP-DLeuβ-
406β-406β-DLeuβ hydrogel construct is shown in Figure S5.1. 
 
5.3.4 Circular Dichroism Spectroscopy  
100 µM protein samples were incubated with 10 mM CaCl2 and were analyzed on a J-
815 circular dichroism (CD) spectrometer (Jasco), where a quartz cuvette with 0.1 mm 
path length was used. Calcium titration was performed with wild-type β-roll, DLeu β-roll 
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and 406 β-roll, where calcium concentration ranged between 0 and 10 mM. The data 
were fit to the Hill equation using SigmaPlot software.  
 
5.3.5 Hydrogel Sample Preparation  
13.2 wt % hydrogel samples were prepared in a similar way for both constructs. The total 
volume prior to lyophilization was 250, 500 or 1000 µL (in 5 mM Tris, pH 7.4) 
depending on the experiment. The samples were supplemented with 50 mM CaCl2 or 
MgCl2. Prepared solutions were frozen overnight and lyophilized the next day for 24 hr. 
The lyophilized protein powder was resuspended in 1/10 of the original sample volume 
(in deionized water (DI) water or in DI water supplemented with 35 µM FITC-labeled 
lysozyme). The samples were left at 4 °C overnight for proper rehydration, after 
mechanical mixing and centrifugation.  
 
5.3.6 FITC-labeled Lysozyme Retention Experiments 
35 µM FITC-labeled lysozyme in 1 mL of 50 mM Tris buffer supplemented with 50 mM 
CaCl2 or MgCl2 was added to hydrogel samples in eppendorfs, resuspended in DI water. 
After an hour of incubation, the samples were washed for 5 rounds by replacing 900 µL 
of the buffer with fresh Tris buffer supplemented with CaCl2 or MgCl2. After the final 
wash step, the samples were scooped out with a spatula, placed on a thin glass slide and 




5.3.7 Hydrogel Erosion Experiments 
1 mL of 50 mM Tris buffer supplemented with 50 mM CaCl2 was added to hydrogel 
samples resuspended in 35 µM FITC-labeled lysozyme solution. Total protein release and 
FITC release were recorded over time by measuring the absorbance at 280 nm and the 
fluorescence at excitation/emission wavelengths of 490/520 nm. The experiments were 
performed in triplicate for each hydrogel construct. 
 
5.4 Results 
5.4.1 Characterization of Mutant β-roll Domains 
Wild-type, DLeu and 406 β-roll domains were analyzed by CD in the presence and 
absence of calcium (0 and 10 mM CaCl2). The CD spectra of the three β-roll peptides are 
shown in Figures 5.2A-C. In the absence of calcium, the spectra exhibited large negative 
peaks at 198-200 nm, which is characteristic of randomly coiled proteins. In the presence 
of 10 mM CaCl2, these peaks shifted to 218 nm, which demonstrated the transition to a 
secondary structure dominated by β-sheets. In addition, a calcium titration experiment 
was performed. The CD signal at 218 nm was recorded for each sample, at different 
calcium concentrations, ranging from 0 to 10 mM. The data are presented in Figure 5.2D. 
Calcium binding affinities of β-roll domains were determined by fitting the CD data to 
the Hill equation, which are tabulated in Table 5.1. DLeu and 406 β-roll domains bound 
calcium with similar affinities compared to wild-type β-roll. All peptides exhibited 














Figure 5.2 Circular dichroism spectra of β-rolls. (A)-(C) show the MREs recorded 
over a range of wavelengths, for wild-type, DLeu and 406 β-rolls, in the presence (ο ο ο) 
and absence (−) of 10 mM CaCl2. The relative MREs at 218 nm are given in (D). 
Table 5.1 Calcium binding properties of β-roll domains 
β-roll Kd (mM) N R2 
WT 0.9 ± 0.1 2.4 ± 0.1 0.997 
DLeu 1.2 ± 0.1 4.6 ± 0.3 0.998 
406 1.2 ± 0.1 2.9 ± 0.1 0.998 
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5.4.2 Lysozyme Retention on the Hydrogel Surfaces  
13.2 wt %, 100 µL samples were prepared for both hydrogel constructs, with either 50 
mM CaCl2 or 50 mM MgCl2. Pictures of samples with calcium and magnesium are 
shown in Figure S5.2. Protein samples with magnesium stayed as viscous solutions 
whereas samples prepared with calcium transitioned to an elastic state and could be easily 
picked up from the eppendorf tube with a spatula.  
 35 µM lysozyme (0.5 mg in 1 mL 50 mM Tris buffer supplemented with calcium 
or magnesium) was added to the protein samples and incubated for an hour. Each sample 
was washed 5 times by replacing the buffer in the eppendorf tube with fresh Tris buffer 
supplemented with salt, thus discarding the unbound lysozyme molecules. The tubes 
were visualized under the UV light, and the pictures taken after the 4th and 5th rounds of 
wash are shown in Figure S5.3. 
 After the final wash step, the buffer was discarded and the protein samples were 
scooped out with a spatula, placed on a glass slide and visualized both under visible light 
and under UV light to detect the FITC presence. As presented in Figure 5.3, only the 
hydrogel construct with the 406 β-roll domain was capable of forming interactions with 
the FITC-labeled lysozyme and retaining it on the hydrogel surface, as demonstrated by 







Figure 5.3 Pictures of protein samples taken after incubation with FITC-labeled 
lysozyme. Samples with magnesium stayed as viscous solutions whereas calcium ones 
formed hydrogel networks. The surface of MBP-DLeuβ-406β-406β-DLeuβ was covered 
by FITC (as demonstrated by the green color), indicating the presence of lysozyme. 
 
5.4.3 Hydrogel Erosion and FITC-labeled Lysozyme Release Rates 
13.2 wt %, 25 µL and 50 µL samples were prepared for both hydrogel constructs, 
supplemented with 50 mM CaCl2. The lyophilized protein samples were resuspended in 
35 µM lysozyme dissolved in DI water. This way, the lysozyme was entrapped within the 
hydrogels. 1 mL of 50 mM Tris buffer supplemented with calcium was added to all tubes 
and the increase in total protein as well as in the released FITC amounts were plotted 
over time (Fig. 5.4 and Fig. 5.5). 
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Figure 5.4 Total protein release over time. The absorbance at 280 nm was recorded 
over 48 hours for MBP-DLeuβ-WTβ-WTβ-DLeuβ and MBP-DLeuβ-406β-406β-DLeuβ 
with two different hydrogel volumes (25 µL and 50 µL). The error bars denote the SEM 
(n=3). 
 A faster protein release was observed for MBP-DLeuβ-WTβ-WTβ-DLeuβ, in the 
case of both hydrogel volumes (Fig. 5.4). The detected protein amount corresponded to 
the sum of the eroded hydrogels and the lysozyme released from the hydrogels. FITC 
release profile exhibited a similar trend for the first 10 hours, after which the lysozyme 
release started saturating (Fig. 5.5). At the end of the 48 hours, the difference in the total 
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FITC amount was larger for the hydrogels with 50 µL sample volume, among the MBP-
DLeuβ-WTβ-WTβ-DLeuβ and MBP-DLeuβ-406β-406β-DLeuβ constructs. 
 
Figure 5.5 Total FITC release over time. The fluorescence at excitation/emission of 
490/520 nm was recorded over 48 hours for MBP-DLeuβ-WTβ-WTβ-DLeuβ and MBP-
DLeuβ-406β-406β-DLeuβ with two different hydrogel volumes (25 µL and 50 µL). The 
error bars denote the SEM (n=3). 
 At the end of the erosion experiments, pictures of the hydrogel constructs were 
taken under the UV light to visually detect the remaining, entrapped FITC presence. 
MBP-DLeuβ-406β-406β-DLeuβ hydrogels appeared greener as shown in Figure S5.4. 
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5.5 Discussion 
This work focused on exploiting the allosteric regulation of the β-roll scaffold for dual 
functionality. Mutation of the residues on the β-roll faces resulted in mutant peptides with 
new protein interfaces: DLeu β-roll peptide providing hydrophobic faces in its folded 
state, amenable to oligomerization and 406 β-roll peptide, capable of capturing the 
lysozyme target. A stimulus-responsive, smart hydrogel platform was built by combining 
these two β-roll mutants in the same construct. The DLeu β-roll mutants and the 
concatemer of the 406 β-roll were genetically fused to maltose binding protein (MBP). N-
terminal MBP facilitated protein expression as well as protein purification, which was 
conducted via amylose columns. A similar construct was built by replacing the 
concatemer of the 406 β-roll with the one of the wild-type peptide.  
 CD analysis revealed that both mutants responded to increased calcium 
concentrations in a similar way compared to the wild-type β-roll (Fig. 5.2). The shift in 
the minima in the CD spectra confirmed the change in the secondary structure 
(disordered-to-ordered transition) of the peptides upon calcium binding (Fig. 5.2A-C). In 
addition, the titration data were fit to reveal the binding parameters of the peptides for 
calcium. Similar affinities were obtained for calcium (0.9 - 1.2 mM) (Table 5.1). The Hill 
coefficients varied between 2.4 and 4.6, indicating cooperativity. The larger coefficients 
observed for 406 β-roll (2.9) and DLeu β-roll (4.9) suggested that higher concentrations 
of calcium might be required to initiate the transition of the peptide, compared to the 
wild-type β-roll. This effect is most likely caused by the hydrophobic residues on the 
mutant peptide faces. The 406 β-roll has hydrophobic amino acids at 5 positions (out of 
! 181 
8) on one of the peptide’s faces whereas the DLeu β-roll has hydrophobic residues at all 8 
positions of both faces. 
 13.2 wt % protein samples were prepared with 50 mM CaCl2 or 50 mM MgCl2. 
This weight percentage was chosen to normalize the molar cross-linking content to the 4  
wt % samples as described in Chapter 3. Both constructs were incubated with buffer 
containing FITC-labeled lysozyme and washed with fresh Tris buffer for 5 rounds. Gel 
pictures as well as the pictures of the eppendorf tubes were taken (Figs. 5.3, S5.2 and 
S5.3). The samples with magnesium were thick, viscous solutions and they partially 
stayed at the bottom of the eppendorf tube and did not fully dissolve, since each had 13.2 
mg of protein. However, a demonstrable hydrogel formation was observed for both 
constructs in the presence of calcium (Fig. S5.2). MBP-DLeuβ-406β-406β-DLeuβ 
appeared green under the UV light, indicating the FITC-labeled lysozyme presence on 
the hydrogel surface. 
 Same percentage hydrogels were prepared with calcium for both constructs. 
These samples were rehydrated in FITC-labeled lysozyme solution, in order to look at the 
release characteristics of the lysozyme as well as to investigate the hydrogel erosion rate. 
The data were plotted as the amount of total protein and FITC, released over time (Figs. 
5.4 and 5.5, respectively). The total protein release was faster in the case of MBP-DLeuβ-
WTβ-WTβ-DLeuβ, for both 25 µL and 50 µL hydrogel samples. This difference was 
most likely correlated with the faster release of lysozyme, which was entrapped within 
the hydrogels, since the two hydrogels had same characteristics as biomaterials, other 
than their affinity for the lysozyme molecule. Another possible explanation for this 
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difference might result from the ability of lysozyme to dimerize. It has been shown that 
lysozyme tends to associate in dimers.19, 20 This might contribute to the overall stability of 
the MBP-DLeuβ-406β-406β-DLeuβ construct, thus resulting in prolonged erosion of the 
hydrogel.  
 The FITC release profile showed a distinct difference between the two constructs 
for the first 10 hours, where the amount of free FITC in solution was higher for the MBP-
DLeuβ-WTβ-WTβ-DLeuβ. However this difference became less obvious after this data 
point. At the end of the 2 days, the hydrogels were visualized under the UV light as 
shown in Figure S5.4. Although it is not possible to quantify the FITC presence visually, 
the difference in the hydrogel colors suggested a better interaction between the entrapped 
lysozyme and MBP-DLeuβ-406β-406β-DLeuβ construct. 
 The hydrogel produced in this work demonstrates the combined allosteric 
regulation of the viscoelastic properties and lysozyme capturing ability of the DLeu β-roll 
mutant and the 406 β-roll mutant, respectively. These two mutant versions of the β-roll 
peptide lead to the design of a smart, bi-functional and stimulus responsive hydrogel. 
Both the self-assembly and the target entrapment within the hydrogel matrix can be 
controlled by simply adjusting the calcium concentrations. This hydrogel platform can 
be, for instance, utilized for cell-lysis applications, where both network formation and 





 5.6 Supplementary Information 










Figure S5.1 SDS-PAGE analysis of MBP-DLeuβ-406β-406β-DLeuβ. The size of the 
















Figure S5.2 Protein samples in the presence of 50 mM CaCl2 and 50 mM MgCl2. 
Constructs prepared in the presence of magnesium stayed as viscous solutions as 
demonstrated in the pictures on the right, in contrast to calcium samples (as shown in the 


















Figure S5.3 Pictures taken after the 4th and 5th rounds of wash following the 
incubation with FITC-labeled lysozyme. The protein samples in the presence of 
magnesium appeared blue under UV light, indicating the lack of FITC presence (pictures 
on the right). MBP-DLeuβ-406β-406β-DLeuβ construct captured the lysozyme in the 
presence of calcium as indicated by the bright green line on the hydrogel surface as well 

















Figure S5.4 Pictures taken at the end of the hydrogel erosion experiments. The 
hydrogel samples (both constructs in the presence of calcium and in triplicates) were 
visualized under the UV light. More FITC presence was observed in the MBP-DLeuβ-
406β-406β-DLeuβ hydrogels (pictures on the right), independent of the hydrogel volume 








5.6.2 Supplementary Tables 
Table S5.1 Primers used in the cloning of hydrogel constructs 














Table S5.2 Protein primary sequences 





















































* Blue residues represent the DLeu β-roll domain with the capping group. Purple and 
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Conclusion and Future Work 
!
6.1 Summary of the Thesis Work 
Throughout this thesis, various protein-protein interfaces in both natural and synthetic 
systems have been investigated and engineered for biotechnology applications. The 
studied protein interactions involved a wide range of associations, including enzyme-
enzyme oligomerization, an intrinsically disordered, allosterically regulated peptide, the 
β-roll, and the design of de novo interfaces available for interactions, based on the β-roll 
domain.  
 In Chapter 2, interactions between two TCA cycle enzymes (citrate synthase and 
mitochondrial malate dehydrogenase) are examined. We showed that the recombinant 
enzymes assemble in a similar way in vitro compared to their counterparts in vivo. 
Enzyme association studies involved the mutation of positions on the protein interfaces to 
identify the key residues contributing to the complex formation. This approach can 
involve the introduction or removal of charged groups to investigate the effect on the 
stability of the metabolon arrangement.1-4 Mutational analysis was applied to CS-mMDH 
metabolon and two positively charged residues on the complex surface were mutated to 
alanine residues. It was observed that these mutations greatly affected the surface-bound 




 In Chapter 3, the disordered-to-ordered transition of the β-roll peptide is explored 
for biomaterials applications. The amino acid residues located on the β-roll faces were 
mutated to contain leucine residues. This resulted in two hydrophobic interfaces, only 
present in the peptide’s folded conformation. We showed that environmentally 
responsive gelation can be achieved via this mutant β-roll domain, upon calcium binding. 
Different hydrogel constructs were built by fusing the single face and double face leucine 
β-rolls to helical leucine-zipper domains. The leucine zippers cross-link with each other 
independent of the salt concentration.6, 7 However hydrogel formation only takes place in 
the presence of calcium, since the β-rolls need to be in their folded state to position their 
leucine rich faces for additional cross-linking. As the next step, the use of the DLeu β-roll 
mutant was assessed as a stand-alone cross-linking domain where calcium dependent 
gelation was demonstrated in a construct composed of the concatemer of this peptide and 
maltose binding protein.8 
 Chapter 4 demonstrates the potential of the same β-roll peptide as a scaffold for 
biomolecular recognition applications. One face of the peptide was randomized by 
mutating eight positions to contain other amino acid residues. This library of mutant β-
rolls was selected against the lysozyme target and several mutants were identified with 
better affinities towards the target molecule, compared to the wild-type peptide. Further 
protein engineering tools were applied where the second face of the peptide as well as 
concatemers of the promising mutants were explored. The best mutant (the concatemer of 
PN406) bound lysozyme with a dissociation constant of 65 ± 28 nM. This mutant was 
used in affinity chromatography applications to demonstrate the use of this new binding 
!
193 
interface to achieve controllable molecular recognition. Target capture and release were 
demonstrated by simply changing the calcium concentration in the environment. The 
mutant immobilized on the chromatography column was capable of forming enough 
interactions with the lysozyme to capture it on the column, in the presence of calcium. 
Target elution was induced upon the transition of the mutant β-roll to its unstructured 
state resulting in the loss of protein interactions. The specificity of this new protein 
interaction was confirmed by repeating the same affinity experiments in the presence of 
non-specific E. coli proteins.9 
 Chapter 5 expands on the research discussed in Chapters 3 and 4. The DLeu β-roll 
mutant and the lysozyme binding β-roll mutant were integrated into a smart hydrogel 
platform. The hydrophobic interfaces of the crosslinking DLeu β-roll domain actuate the 
self-assembly whereas lysozyme binder captures the lysozyme within or on the surface of 
the assembled hydrogel network. By engineering the same residues on the β-roll scaffold 
for different purposes, distinct protein interfaces were constructed and combined in this 
platform. This work presented a smart biomaterial with dual functionality where both the 
assembly and the target capture functions can be controlled via changes in the calcium 
concentration.  
 
6.2 Future Directions 
This thesis demonstrates the importance of understanding and manipulating protein 
interactions via a specific set of examples. The same protein engineering approaches can 
!
194 
be applied to other protein systems. In addition, the discussed work can be further 
improved and built on, in several ways: 
 The knowledge gained from the metabolon work can be utilized to build artificial 
metabolons to be used for smarter catalysis in bioenergy systems. This can be achieved 
via various in vitro strategies including scaffold-mediated co-localization (e.g. peptide 
staples, DNA scaffolds, protein cages).10-12 Moreover, the importance of charged residues 
for enzyme complexes has been demonstrated by others and us. Mimicking nature, 
synthetic systems can be built by taking advantage of this information, where charged 
residues can be introduced to recombinant enzymes on the DNA level, to facilitate the 
transport of intermediates. 
 The hydrogel platforms discussed in Chapters 3 and 5 can be improved and 
further explored by constructing different fusion proteins where the DLeu β-roll domain 
can be appended to any protein of interest. These studies demonstrated the use of this 
mutant for allosterically regulated gelation, which only depends on the calcium presence, 
independent from the rest of the hydrogel components. In addition, a cleavage site can be 
introduced between the N-terminal maltose binding protein and the rest of the construct. 
This way, this large protein (molecular weight: 41 kDa) can be discarded after protein 
expression and purification. This will allow for hydrogel formation at lower overall 
protein content. For the hydrogel construct discussed in Chapter 5, molding into distinct 
shapes was demonstrated (Fig. 6.1). Calcium dependent cell lysis experiments can be 
performed to assess the bi-functionality of this biomaterial, where incubation of lysozyme 
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entrapped within the hydrogel with cells should result in cell death specific to the area 
occupied by the hydrogel. 
 
Figure 6.1 CU (acronym for Columbia University) written with the stimulus-
responsive hydrogel. A protein sample of MBP-DLeuβ-406β-406β-DLeuβ construct 
was used in the presence of 50 mM CaCl2 to initiate network assembly. After hydrogel 
formation, the sample was squeezed through an 18-gauge needle. 
 Lastly, the work discussed in Chapter 4 is very promising for biotechnology 
applications (e.g. bioseparations and biosensors). We showed that the calcium induced 
conformational change of the β-roll peptide can be used as a protein switch to control the 
activation of the binding interface, and thus the binding event. Hen egg white lysozyme 
was chosen as the target protein, being one of the very well investigated, model proteins 
for directed evolution studies. However, the same technology can be used to identify β-
roll mutants demonstrating an affinity towards other targets. Based on the recently 
resolved crystal structure of the peptide, additional residues in the capping domain of the 
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peptide can be randomized to increase the evolved surface area.13 One of the most 
exciting targets would be the constant region of a human IgG antibody. Combining our 
selection platform with protein engineering tools (e.g. building concatemers to enlarge 
the protein interaction surface), mutants demonstrating an affinity for antibodies can be 
identified. The best part of using this allosterically-regulated peptide is that target elution 
is easily achieved upon a single switch in the chromatography buffer condition. This will 
greatly improve antibody purification and potentially replace Protein A-oriented 
separations. The evolved peptides can be used as reusable, high-affinity ligands for 
bioseparations applications. Our studies demonstrated the use of conformationally 
dynamic or instrinsically disordered motifs in biomolecular recognition, which has been 
largely unexplored, and may assist the rational design of future allosterically-regulated 
scaffolds to carry out controllable molecular recognition playing an important role in 
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